CA2221332C - Contraceptive transcervical fallopian tube occlusion devices and their delivery - Google Patents
Contraceptive transcervical fallopian tube occlusion devices and their delivery Download PDFInfo
- Publication number
- CA2221332C CA2221332C CA002221332A CA2221332A CA2221332C CA 2221332 C CA2221332 C CA 2221332C CA 002221332 A CA002221332 A CA 002221332A CA 2221332 A CA2221332 A CA 2221332A CA 2221332 C CA2221332 C CA 2221332C
- Authority
- CA
- Canada
- Prior art keywords
- fallopian tube
- intrafallopian
- contraceptive device
- elongate body
- primary coil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
- A61F6/20—Vas deferens occluders; Fallopian occluders
- A61F6/22—Vas deferens occluders; Fallopian occluders implantable in tubes
- A61F6/225—Vas deferens occluders; Fallopian occluders implantable in tubes transcervical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/1214—Coils or wires
- A61B17/12145—Coils or wires having a pre-set deployed three-dimensional shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/1214—Coils or wires
- A61B17/1215—Coils or wires comprising additional materials, e.g. thrombogenic, having filaments, having fibers, being coated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
- A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
- A61F6/14—Contraceptive devices; Pessaries; Applicators therefor for use by females intra-uterine type
- A61F6/18—Inserters or removers ; Apparatus for loading an intra-uterine device into an insertion tube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
- A61F6/20—Vas deferens occluders; Fallopian occluders
- A61F6/22—Vas deferens occluders; Fallopian occluders implantable in tubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B2017/1205—Introduction devices
Abstract
The invention provides intra-fallopian devices and non-surgical methods for their placement to prevent conception.
The efficacy of the device (10) is enhanced by forming the structure at least in part from copper or a copper alloy. The device (10) is anchored within the fallopian tube by imposing a secondary shape on a resilient structure, the secondary shape having a larger cross section than the fallopian tube. The resilient structure is restrained in a straight configuration and trans-cervical inserted within the fallopian tube, where it is released. The resilient structure is then restrained by the walls of the fallopian tube, imposing anchoring forces as it tries to resume the secondary shape.
The efficacy of the device (10) is enhanced by forming the structure at least in part from copper or a copper alloy. The device (10) is anchored within the fallopian tube by imposing a secondary shape on a resilient structure, the secondary shape having a larger cross section than the fallopian tube. The resilient structure is restrained in a straight configuration and trans-cervical inserted within the fallopian tube, where it is released. The resilient structure is then restrained by the walls of the fallopian tube, imposing anchoring forces as it tries to resume the secondary shape.
Description
CONTRACEPTIVE TRANSCERVICAL FALLOPIAN
TUBE OCCLUSION DEVICES AND THEIR DELIVERY
BACKGROUND OF THE INVENTION
1. Field of the Invention The present invention relates generally to contraception, and more particularly to intrafallopian contraceptive devices and nonsurgical methods for their delivery.
Worldwide demand exists for safe, effective methods of both contraception and permanent sterilization. Although a variety of contraception and sterilization methods are available, all of the existing methods have limitations and disadvantages. Thus, the need for additional safe, low cost, reliable methods of contraception and permanent sterilization, both in developed and less developed countries, is widely recognized.
Many presently available contraception methods require significant user involvement, and user non-compliance results in quite high rates of failure. While the theoretical effectiveness of existing contraceptives, including barrier methods and hormonal therapies, is well established, overcoming user noncompliance to improve overall efficacy has proven difficult.
One form of contraception which is less susceptible to user noncompliance is the intrauterine device (IUD). IUDs have been found to have higher rates of reliability, and are effective for a longer period of time, than most other commercially available contraceptives. Unfortunately, IUDs are also associated with serious infectious complications.
For this reason, the use of IUDs within the United States has decreased dramatically. Additionally, IUDs are subject to unplanned expulsion, and must be removed due to excessive pain or bleeding in a percentage of cases, further reducing the acceptance of the IUD as a contraceptive method.
TUBE OCCLUSION DEVICES AND THEIR DELIVERY
BACKGROUND OF THE INVENTION
1. Field of the Invention The present invention relates generally to contraception, and more particularly to intrafallopian contraceptive devices and nonsurgical methods for their delivery.
Worldwide demand exists for safe, effective methods of both contraception and permanent sterilization. Although a variety of contraception and sterilization methods are available, all of the existing methods have limitations and disadvantages. Thus, the need for additional safe, low cost, reliable methods of contraception and permanent sterilization, both in developed and less developed countries, is widely recognized.
Many presently available contraception methods require significant user involvement, and user non-compliance results in quite high rates of failure. While the theoretical effectiveness of existing contraceptives, including barrier methods and hormonal therapies, is well established, overcoming user noncompliance to improve overall efficacy has proven difficult.
One form of contraception which is less susceptible to user noncompliance is the intrauterine device (IUD). IUDs have been found to have higher rates of reliability, and are effective for a longer period of time, than most other commercially available contraceptives. Unfortunately, IUDs are also associated with serious infectious complications.
For this reason, the use of IUDs within the United States has decreased dramatically. Additionally, IUDs are subject to unplanned expulsion, and must be removed due to excessive pain or bleeding in a percentage of cases, further reducing the acceptance of the IUD as a contraceptive method.
Interestingly, the efficacy of copper IUDs appears to be higher than that of non-metallic ItJDs. The reason for this has not been fully explained.
Commercially available options for permanent sterilization include fallopian tube ligation and vasectomy.
These methods are surgical, are difficult to reverse, and are not available to many people in the world. It is common knowledge that fertilization occurs in the fallopian tubes where the sperm and ovum meet. Tubal ligation avoids this by complete occlusion of the fallopian tubes.
It has previously been proposed to reversibly occlude the fallopian tubes, for example, by in vitro formation of an elastomeric plug, or otherwise anchoring a device on either side of the narrowest region of fallopian tube, called the "isthmus." Such fallopian tube occlusion methods appear promising; however, an unacceptably high percentage of the non-surgical devices proposed to date have become dislodged during previous studies. Even where non-surgical intrafallopian devices have remained in place, they have been found to be only moderately effective at preventing conception.
For these reasons, it would be desirable to provide effective, reliable intrafallopian devices for contraception and sterilization. It would be particularly desirable to provide highly effective intrafallopian devices which did not require surgery for placement. It would be especially desirable if such devices and methods allowed easy placement of the device, but were less susceptible to being dislodged than previously proposed non-surgical intrafallopian devices.
2. Description of the Related Art The experimental use of a stainless steel intrafallopian device is described in Transcatheter Tubal Sterilization in Rabbits, Penny L. Ross, RT 29 "Investigative 35 Radiology", pp. 570-573 (1994). The experimental use of an electrolytically pure copper wire as a surgical contraceptive intrafallopian device in rats was described in "Antifertility Effect of an Intrafallopian Tubal Copper Device", D.N. Gupta, 14 Indian Journal of Experimenta.Z Biology, pp. 316-319 (May 1976).
U.K. Patent Application Pub. No. 2,211,095 describes a uterine screw plug for blocking the fallopian tube.
European Patent Application Pub. No. 0,010,812 describes a device for placement in the oviducts having enlargements at either end for anchoring the device. The same device appears to be described in Netherlands Patent No. 7,810,696.
The use of tubal occlusion devices is described in "Hysteroscopic Oviduct Blocking With Formed-in-Place Silicone Rubber Plugs", Robert A. Erb, Ph.D., et al., The Journal of Reproductive Medicine, pp. 65-68 (August 1979). A
formed-in-place elastomeric tubal occlusion device is described in U.S. Patent No. 3,805,767, issued to Erb. U.S.
Patent No. 5,065,751, issued to Wolf, describes a method and apparatus for reversibly occluding a biological tube. U.S.
Patent No. 4,612,924, issued to Cimber, describes an intrauterine contraceptive device which seals the mouths of the fallopian tubes.
German Patent No. 28 03 685, issued to Brundin, describes a device for plugging a body duct with a device which swells when in contact with a body fluid.
Alternative contraceptive devices are disclosed in U.S. Patent Nos. 6,705,323;'6.684,884; 6,634,361;
and 6, 52 6, 97 9. .
SUNIlMARY OF THE INVENTION
The present invention provides intrafallopian devices and methods for their placement to prevent conception.
The intrafallopian devices of the present invention are transcervically delivered, resiliently anchored structures which are formed at least in part from copper to provide long term contraception, or alternatively permanent sterilization, without the need for surgical procedures or the increased bleeding, pain, and risks of infection associated with intrauterine devices (IUDs).
Commercially available options for permanent sterilization include fallopian tube ligation and vasectomy.
These methods are surgical, are difficult to reverse, and are not available to many people in the world. It is common knowledge that fertilization occurs in the fallopian tubes where the sperm and ovum meet. Tubal ligation avoids this by complete occlusion of the fallopian tubes.
It has previously been proposed to reversibly occlude the fallopian tubes, for example, by in vitro formation of an elastomeric plug, or otherwise anchoring a device on either side of the narrowest region of fallopian tube, called the "isthmus." Such fallopian tube occlusion methods appear promising; however, an unacceptably high percentage of the non-surgical devices proposed to date have become dislodged during previous studies. Even where non-surgical intrafallopian devices have remained in place, they have been found to be only moderately effective at preventing conception.
For these reasons, it would be desirable to provide effective, reliable intrafallopian devices for contraception and sterilization. It would be particularly desirable to provide highly effective intrafallopian devices which did not require surgery for placement. It would be especially desirable if such devices and methods allowed easy placement of the device, but were less susceptible to being dislodged than previously proposed non-surgical intrafallopian devices.
2. Description of the Related Art The experimental use of a stainless steel intrafallopian device is described in Transcatheter Tubal Sterilization in Rabbits, Penny L. Ross, RT 29 "Investigative 35 Radiology", pp. 570-573 (1994). The experimental use of an electrolytically pure copper wire as a surgical contraceptive intrafallopian device in rats was described in "Antifertility Effect of an Intrafallopian Tubal Copper Device", D.N. Gupta, 14 Indian Journal of Experimenta.Z Biology, pp. 316-319 (May 1976).
U.K. Patent Application Pub. No. 2,211,095 describes a uterine screw plug for blocking the fallopian tube.
European Patent Application Pub. No. 0,010,812 describes a device for placement in the oviducts having enlargements at either end for anchoring the device. The same device appears to be described in Netherlands Patent No. 7,810,696.
The use of tubal occlusion devices is described in "Hysteroscopic Oviduct Blocking With Formed-in-Place Silicone Rubber Plugs", Robert A. Erb, Ph.D., et al., The Journal of Reproductive Medicine, pp. 65-68 (August 1979). A
formed-in-place elastomeric tubal occlusion device is described in U.S. Patent No. 3,805,767, issued to Erb. U.S.
Patent No. 5,065,751, issued to Wolf, describes a method and apparatus for reversibly occluding a biological tube. U.S.
Patent No. 4,612,924, issued to Cimber, describes an intrauterine contraceptive device which seals the mouths of the fallopian tubes.
German Patent No. 28 03 685, issued to Brundin, describes a device for plugging a body duct with a device which swells when in contact with a body fluid.
Alternative contraceptive devices are disclosed in U.S. Patent Nos. 6,705,323;'6.684,884; 6,634,361;
and 6, 52 6, 97 9. .
SUNIlMARY OF THE INVENTION
The present invention provides intrafallopian devices and methods for their placement to prevent conception.
The intrafallopian devices of the present invention are transcervically delivered, resiliently anchored structures which are formed at least in part from copper to provide long term contraception, or alternatively permanent sterilization, without the need for surgical procedures or the increased bleeding, pain, and risks of infection associated with intrauterine devices (IUDs).
The use of copper in the intrafallopian device of the present invention improves its efficacy as a contraceptive method. Devices formed from plastically deformable materials, however, are less readily restrained in the fallopian tube.
Apparently, the large variation in the actual shape and dimensions of fallopian tubes does not provide reliable anchoring for a pre-formed deformable intrafallopian device.
The intrafallopian device of the present invention therefore comprises a resilient structure, usually a metallic coil, which includes a copper alloy, a copper plating, or copper fibers, ideally comprising an alloy including at least 75%
copper. The coil material typically includes beryllium, zinc, stainless steel, platinum, a shape memory alloy such as Nitinoior the like. Preferably, the coil is composed of an alloy of beryllium and copper. Although the present device will generally result in occlusion, it need not completely occlude the fallopian tube to prevent the meeting of the sperm and ovum. Instead, the presence of the copper on the resilient structure is sufficient to provide effective contraception.
Conveniently, the present invention further comprises non-surgical placement of such intrafallopian devices by transcervical introduction. The resilient structure is restrainable in a straight configuration, e.g., by inserting the device within a catheter, greatly facilitating and reducing the risks of introduction. Thus, the cost and dangers associated with existing surgical contraceptive and sterilization procedures are avoided.
In a first aspect, a contraceptive intrafallopian device according to the present invention comprises a resilient structure having a proximal end and a distal end.
The resilient structure comprises copper, and is biased to form at least one bend near the proximal end of the primary coil. Similarly, the resilient structure is also biased to form at least one bend near its distal end. These proximal and distal bends define an isthmus-traversing region therebetween. Preferably, the isthmus-traversing region also includes at least one bend, thereby helping to anchor the coil within the fallopian tube.
Generally, the resilient structure of the present intrafallopian device will be formed as a primary coil. To 5 help restrain the coil within the fallopian tube, fibers are attached to some embodiments of the coil, the fibers optionally comprising a polyester material such as Rayon''m, Dacron"`, or the like. Alternatively, copper fibers may be used to increase the exposed copper surface area, the copper fibers generally having a diameter on the order of .001 inches.
The bends of the present intrafallopian device are generally formed as a secondary shape imposed on a primary coil. The primary coil is most easily formed as a straight cylindrical coil. The secondary shape will be imposed on the primary coil by bending, optionally heat treating the primary coil while bent. The individual bends may take a wide variety of forms, including sinusoidal curves, the individual loops of a continuous secondary coil, or the like. However, the secondary shape generally defines an overall width which is larger than the fallopian tube, so that the tubal wall restrains the resilient structure when it is released.
Preferably, each of the bends of the present intrafallopian device forms a loop in the primary coil when in a relaxed state. Ideally, the loops are separated by straight sections of coil. The alternating of loops with straight sections of coil forms a large diameter "flower coil," which provides a large relaxed overall width, and also features bends of tight radius, both of which promote retention.
Conveniently, the primary coil generally has a diameter less than that of the fallopian tube, and can be restrained in a straight configuration for placement within the fallopian tube, typically by inserting the primary coil within a delivery catheter.
In another aspect, a contraceptive intrafallopian device according to the present invention comprises a resilient primary coil having a primary coil diameter. The primary coil comprises copper, and forms a secondary shape when in a relaxed state. The secondary shape defines a plurality of bends and an overall width which is larger than the primary coil diameter. Thus the primary coil can be easily anchored in a fallopian tube which is smaller in diameter than the secondary shape. Preferably, the present device reacts with a force sufficient to prevent axial movement of the device within the fallopian tube when restrained in a lumen having a diameter in the range between .5 mm and 3 mm. The actual anchoring force will depend on the shape of the coil and the modulus of elasticity of the material used.
In yet another aspect, a intrafallopian contraceptive delivery system according to the present invention comprises an elongate body in which the resilient primary coil described above is slidably disposed. A shaft is also slidably disposed within the elongate body and is located proximally of the primary coil. The distal end of the shaft includes a coil interface surface, while the elongate body restrains the primary coil in a straight configuration.
Preferably, a bend in the isthmus-traversing region of the present intrafallopian device, together with the proximal and distal anchor bends, restrains the resilient structure within the isthmus of the fallopian tube. The distal anchor is inserted into the ampulla, distal of the isthmus, while the proximal anchor is located in the ostium, proximal of the isthmus. Unintended movement of the device is further avoided by locating the isthmus-traversing region within the isthmus to resiliently impose anchoring forces against the tubal wall.
In a still further aspect, an intrafallopian contraceptive method according to the principles of the present invention comprises restraining a resilient structure in a straight configuration and transcervically inserting the resilient structure into a fallopian tube. The resilient structure is affixed within the isthmus by releasing a bent isthmus-traversing region. The bend of the isthmus-traversing region exerts a force against the wall of the fallopian tube, anchoring the device within the isthmus. Preferably, a distal anchor on the resilient structure is released distally of the isthmus, and a proximal anchor is released proximally of the isthmus, the distal and proximal anchors generally formed from bends in the resilient structure. Optionally, an electric current is applied through the resilient structure to the fallopian tube, thereby effecting permanent sterilization.
BRIEF DESCRIPTION OF THE DRAWINGS
Fig. 1 illustrates a first embodiment of a contraceptive intrafallopian device according to the present invention having a single distal anchor loop, a single proximal anchor loop, and an isthmus-traversing region having a single loop for anchoring the device within the fallopian tube.
Fig. 2 illustrates an alternative embodiment of a contraceptive intrafallopian device according to the present invention having a plurality of loops which may act as proximal, distal, or lumen anchors.
Fig. 3 illustrates the distal portion of a delivery catheter for placement of a contraceptive intrafallopian device according to the present invention.
Fig. 4 illustrates the contraceptive intrafallopian device of Fig. 1 partially released from the delivery catheter of Fig. 3.
Figs. 5 and 6 illustrate a contraceptive method using an intrafallopian device according to the principles of the present invention.
DETAILED DESCRIPTION OF THE SPECIFIC EMBODIMENT
The present invention encompasses a contraceptive intrafallopian device which can alternatively be used as both a permanent and a reversible means of contraception. The present contraceptive methods and devices minimize the danger of non-use which has limited the efficacy of prior art contraceptive techniques. Moreover, the location of the present devices within the fallopian tubes provides a reduced risk of the infectious complications, increased bleeding, and pelvic pain associated with intrauterine devices (IUDs).
Apparently, the large variation in the actual shape and dimensions of fallopian tubes does not provide reliable anchoring for a pre-formed deformable intrafallopian device.
The intrafallopian device of the present invention therefore comprises a resilient structure, usually a metallic coil, which includes a copper alloy, a copper plating, or copper fibers, ideally comprising an alloy including at least 75%
copper. The coil material typically includes beryllium, zinc, stainless steel, platinum, a shape memory alloy such as Nitinoior the like. Preferably, the coil is composed of an alloy of beryllium and copper. Although the present device will generally result in occlusion, it need not completely occlude the fallopian tube to prevent the meeting of the sperm and ovum. Instead, the presence of the copper on the resilient structure is sufficient to provide effective contraception.
Conveniently, the present invention further comprises non-surgical placement of such intrafallopian devices by transcervical introduction. The resilient structure is restrainable in a straight configuration, e.g., by inserting the device within a catheter, greatly facilitating and reducing the risks of introduction. Thus, the cost and dangers associated with existing surgical contraceptive and sterilization procedures are avoided.
In a first aspect, a contraceptive intrafallopian device according to the present invention comprises a resilient structure having a proximal end and a distal end.
The resilient structure comprises copper, and is biased to form at least one bend near the proximal end of the primary coil. Similarly, the resilient structure is also biased to form at least one bend near its distal end. These proximal and distal bends define an isthmus-traversing region therebetween. Preferably, the isthmus-traversing region also includes at least one bend, thereby helping to anchor the coil within the fallopian tube.
Generally, the resilient structure of the present intrafallopian device will be formed as a primary coil. To 5 help restrain the coil within the fallopian tube, fibers are attached to some embodiments of the coil, the fibers optionally comprising a polyester material such as Rayon''m, Dacron"`, or the like. Alternatively, copper fibers may be used to increase the exposed copper surface area, the copper fibers generally having a diameter on the order of .001 inches.
The bends of the present intrafallopian device are generally formed as a secondary shape imposed on a primary coil. The primary coil is most easily formed as a straight cylindrical coil. The secondary shape will be imposed on the primary coil by bending, optionally heat treating the primary coil while bent. The individual bends may take a wide variety of forms, including sinusoidal curves, the individual loops of a continuous secondary coil, or the like. However, the secondary shape generally defines an overall width which is larger than the fallopian tube, so that the tubal wall restrains the resilient structure when it is released.
Preferably, each of the bends of the present intrafallopian device forms a loop in the primary coil when in a relaxed state. Ideally, the loops are separated by straight sections of coil. The alternating of loops with straight sections of coil forms a large diameter "flower coil," which provides a large relaxed overall width, and also features bends of tight radius, both of which promote retention.
Conveniently, the primary coil generally has a diameter less than that of the fallopian tube, and can be restrained in a straight configuration for placement within the fallopian tube, typically by inserting the primary coil within a delivery catheter.
In another aspect, a contraceptive intrafallopian device according to the present invention comprises a resilient primary coil having a primary coil diameter. The primary coil comprises copper, and forms a secondary shape when in a relaxed state. The secondary shape defines a plurality of bends and an overall width which is larger than the primary coil diameter. Thus the primary coil can be easily anchored in a fallopian tube which is smaller in diameter than the secondary shape. Preferably, the present device reacts with a force sufficient to prevent axial movement of the device within the fallopian tube when restrained in a lumen having a diameter in the range between .5 mm and 3 mm. The actual anchoring force will depend on the shape of the coil and the modulus of elasticity of the material used.
In yet another aspect, a intrafallopian contraceptive delivery system according to the present invention comprises an elongate body in which the resilient primary coil described above is slidably disposed. A shaft is also slidably disposed within the elongate body and is located proximally of the primary coil. The distal end of the shaft includes a coil interface surface, while the elongate body restrains the primary coil in a straight configuration.
Preferably, a bend in the isthmus-traversing region of the present intrafallopian device, together with the proximal and distal anchor bends, restrains the resilient structure within the isthmus of the fallopian tube. The distal anchor is inserted into the ampulla, distal of the isthmus, while the proximal anchor is located in the ostium, proximal of the isthmus. Unintended movement of the device is further avoided by locating the isthmus-traversing region within the isthmus to resiliently impose anchoring forces against the tubal wall.
In a still further aspect, an intrafallopian contraceptive method according to the principles of the present invention comprises restraining a resilient structure in a straight configuration and transcervically inserting the resilient structure into a fallopian tube. The resilient structure is affixed within the isthmus by releasing a bent isthmus-traversing region. The bend of the isthmus-traversing region exerts a force against the wall of the fallopian tube, anchoring the device within the isthmus. Preferably, a distal anchor on the resilient structure is released distally of the isthmus, and a proximal anchor is released proximally of the isthmus, the distal and proximal anchors generally formed from bends in the resilient structure. Optionally, an electric current is applied through the resilient structure to the fallopian tube, thereby effecting permanent sterilization.
BRIEF DESCRIPTION OF THE DRAWINGS
Fig. 1 illustrates a first embodiment of a contraceptive intrafallopian device according to the present invention having a single distal anchor loop, a single proximal anchor loop, and an isthmus-traversing region having a single loop for anchoring the device within the fallopian tube.
Fig. 2 illustrates an alternative embodiment of a contraceptive intrafallopian device according to the present invention having a plurality of loops which may act as proximal, distal, or lumen anchors.
Fig. 3 illustrates the distal portion of a delivery catheter for placement of a contraceptive intrafallopian device according to the present invention.
Fig. 4 illustrates the contraceptive intrafallopian device of Fig. 1 partially released from the delivery catheter of Fig. 3.
Figs. 5 and 6 illustrate a contraceptive method using an intrafallopian device according to the principles of the present invention.
DETAILED DESCRIPTION OF THE SPECIFIC EMBODIMENT
The present invention encompasses a contraceptive intrafallopian device which can alternatively be used as both a permanent and a reversible means of contraception. The present contraceptive methods and devices minimize the danger of non-use which has limited the efficacy of prior art contraceptive techniques. Moreover, the location of the present devices within the fallopian tubes provides a reduced risk of the infectious complications, increased bleeding, and pelvic pain associated with intrauterine devices (IUDs).
Furthermore, the location and the novel shape of the present intrafallopian device provides significant advantages over IUDs, which have been found to be susceptible to unplanned expulsion and removal due to excessive pain and bleeding. The present invention takes advantage of the increase in effectiveness associated with copper IUDs, providing a resilient structure including copper which may be transcervically positioned without the need for surgery.
Although the present contraceptive method may be included within a group of contraceptive techniques generally referred to as fallopian tube occlusion methods, the present invention does not necessarily rely solely on blocking the fallopian tube to prevent fertilization. Instead, contraception is apparently provided by disrupting of ovum transport, the process of fertilization, and/or cleavage of the ovum. While the effect that copper has on these processes is not fully understood, it does appear that copper intrafallopian devices offer potentially significant increases in effectiveness over intrafallopian devices formed of other materials. Optionally, the present invention further encompasses devices which promote tissue growth within the tube to induce tubal occlusion, further inhibiting conception.
The present invention is anchored within the isthmus of the fallopian tube, overcoming the unintended expulsion of the device and the resulting failure of the contraceptive method. Such intrafallopian device expulsion has been the single greatest factor limiting the efficacy of easily positioned intrafallopian contraceptive techniques.
The present intrafallopian devices are generally elongate resilient structures pre-formed into secondary shapes. These secondary shapes will bias the resilient structure so as to provide strong forces against the lumen wall of the fallopian tube. Clearly, the secondary shape must have a larger outer diameter than the inner diameter of the fallopian tube.
Conveniently, the present resilient structures are insertable into a catheter, the catheter wall restraining the resilient structure in a straight configuration. As the resilient structure has an outer diameter when in the straight configuration which is less than the inner diameter of the fallopian tube, the catheter containing the present intrafallopian device is easily transcervically introduced.
Moreover, the device is readily removed by snaring the resilient structure near the proximal end and pulling proximally on the resilient structure, thereby straightening the resilient structure and allowing it to be withdrawn without injuring the fallopian tube. Alternatively, an electrical current is applied to the device after it is at least partially releasing the fallopian tube, providing permanent sterilization.
Referring now to Fig. 1, a first embodiment of the present contraceptive intrafallopian device 10 is formed from a resilient primary coil 12. Primary coil 12 is most easily originally formed as a straight cylindrical coil or spring, preferably having an outer diameter in the range from .2 mm to 5 mm, and having a length in the range from 20 mm to 150 mm.
Ideally, primary coil 12 has an outer diameter in the range from .4 mm to 2 mm and a length in the range from 30 mm to 70 mm. The straight primary coil may then be bent into a variety of secondary shapes.
The primary coil 12 of intrafallopian device 10 includes a proximal end 14 and a distal end 16. Between these ends, three loops 20 are formed, each having an inner diameter 22. Located between loops 20 are straight sections 24, which increase the overall cross-section of the intrafallopian device to an overall width 26. Preferably, inner diameter 22 is in the range from 2 mm to 10 mm, while overall width 26 is at least 6mm, ideally being in the range from 8 mm to 40 mm. Distal and proximal ends 14, 16 each include an atraumatic endcap 18 to prevent injury to the fallopian tube.
Preferably, primary coil 12 is formed from a beryllium copper alloy wire. Beryllium copper provides the resilience necessary to avoid expulsion of the device, and also provides the increased effectiveness of a copper contraceptive intrafallopian device. Alternatively, primary coil 12 is formed from a resilient metal, such as stainless steel, platinum, a shape memory alloy, or the like. If such materials are used, primary coil 12 is preferably plated with copper or a copper alloy or otherwise has copper attached.
5 To further reduce the possibility of expulsion of intrafallopian device 10, fibers are optionally carried on primary coil 12. The fibers may be short individual fibers, or may alternatively be wound into primary coil 12.
Preferably, the fibers comprise copper, thereby increasing the 10 total copper surface area. Such copper fibers are preferably bonded to primary coil 12 with solder, brazing, a polymeric adhesive, or the like. Alternatively, polyester fibers such as DacronT", Rayon, or the like, are bonded to the surface of primary coil 12 using a polymeric adhesive. The polyester fibers promote increased tissue growth around the coil, thus further reducing the possibility of expulsion of the device from the fallopian tube.
A secondary shape has been superimposed on the primary coil to form intrafallopian device 10, the secondary shape comprising loops 20 separated by straight sections 24.
This secondary shape is herein referred to as a "flower coil."
The flower coil shape is particularly advantageous in that outer diameter 26 is substantially larger than the primary coil diameter, while the individual loops 20 have relatively small inner diameters 22 which will maintain the largest possible anchoring force against the fallopian tube.
Minimizing inner diameter 22 also ensures that anchoring force is applied within the fallopian tube, despite the curvature of the fallopian tube.
Referring now to Fig. 2, an alternative embodiment of the present contraceptive intrafallopian device 30 includes additional loops to ensure anchoring of the device within the fallopian tube. Alternative embodiment 30 is formed from an =
elongate primary coil 32 having a proximal end 34 and a distal end (not shown). Elongate primary coil 32 has an outer diameter 36 which is smaller than the isthmus of the fallopian tube, allowing the straightened intrafallopian device to be inserted easily. Elongate primary coil 32 has been bent to form a secondary shape including a larger number of loops 38 than the embodiment of Fig. 1. Loops 38 have an outer diameter 40 which is larger than the inner diameter of the fallopian tube, preventing loops 38 from assuming their relaxed shape. Loops 38 are again separated by straight sections 42 of elongate primary coil 32, increasing the " overall intrafallopian device diameter 44.
In both embodiments of the present intrafallopian device 10, 30, at least one loop adjacent to the proximal end is disposed proximally of the narrowest portion of the fallopian tube, referred to as the isthmus. Similarly, at least one loop of the intrafallopian device is disposed distally of the isthmus. These proximal and distal loops act as anchors, helping to prevent proximal or distal movement of the intrafallopian device. In the embodiment of Fig. 2, at least one loop is also disposed adjacent to the isthmus of the fallopian tube, further helping to prevent unintentional expulsion.
Alternative intrafallopian device 30 may be positioned with multiple loops acting as proximal or distal anchors, or may alternatively have all but the proximal and distal anchor loops disposed along the fallopian tube to act as anchors within the lumen of that body. Advantageously, the embodiment of Fig. 2 is therefore less sensitive to variations in total fallopian tube length.
Referring now to Fig. 3, a delivery catheter for the present intrafallopian device comprises an elongate body 52 and a shaft 54. Elongate body 52 includes a lumen 56 in which shaft 54 is disposed, shaft 54 being slidable in the axial direction. Shaft 54 includes a core 58 having a tapered distal end 60, allowing the device to navigate through tortuous bends while retaining the column strength required to advance the device. Core 58 extends proximally through elongate body 52, and is capable of transferring compressive forces through the elongate body. Core 58 is typically formed from stainless steel, a stainless alloy, or the like.
Disposed over distal end 60 of core 58 is pusher cap 62.
Pusher cap 62 provides a low friction, deformable end piece having a distal coil interface surface 64. Pusher cap 62 is preferably formed of a low friction polymer such as PTFE, or the like.
Intrafallopian delivery catheter 50 receives the present intrafallopian device within the distal end of lumen 56 of elongate body 52. Lumen 56 has an inner diameter which is slightly larger than outer diameter 36 of the primary ~
coil. The present intrafallopian device is therefore straightened to a straight configuration as it is loaded proximally into the distal end of lumen 56. Elongate body 52 is sufficiently strong to restrain the primary coil in the straight configuration, but must remain sufficiently flexible to allow maneuvering within the body lumen. Elongate body 52 is preferably formed from an inelastic, flexible material such as polyurethane, PET, or the like.
Referring now to Fig. 4, intrafallopian device 10 is released from delivery catheter 50 within the fallopian tube by holding shaft 54 while proximally withdrawing elongate body 52. Distal coil interface surface 64 engages the proximal end 14 of primary coil 12. Initially, primary coil 12 is restrained in a straight configuration by elongate body 52.
As elongate body 52 is withdrawn, primary coil 12 is released.
When primary coil 12 is unrestrained it forms loop 20; when released within the fallopian tube it will generally be restrained by the tubal wall in a configuration between straight and the relaxed secondary shape. Preferably, the first loop released will form a distal anchor bend 66.
Subsequent loops will bias primary coil 12 against the fallopian tube, and form a proximal anchor bend, in that order.
Use of the present contraceptive intrafallopian device will be described with reference to Figs. 5 and 6. A
uterine introducer canula 70 is inserted transcervically through a uterus 72 to the region of an ostium 74. Elongate body 52 is then extended distally from canula 70 into a fallopian tube 77, preferably guided under fluoroscopy.
Alternatively, a hysteroscope may be used in place of canula 70. Elongate body 52 is maneuvered using a guide wire 78 past an isthmus 80.
After elongate body 52 extends past isthmus 80, guide wire 78 is removed. An intrafallopian device according to the present invention is inserted in the proximal end of elongate body 52, the intrafallopian device being restrained in a straight configuration by the elongate body. The device is advanced distally using shaft 54, the shaft and elongate body forming delivery catheter 50 (Fig. 3). Delivery catheter 50 is axially positioned so that at least one loop of the intrafallopian device is within a target region 84 adjacent to isthmus 80. Preferably, at least one loop is distal of target region 84, and at least one loop is proximal of target region 84 to form the distal and proximal anchor bends of the implanted intrafallopian device.
Once delivery catheter 50 is properly positioned, elongate body 52 may be axially withdrawn. Shaft 54 axially restrains the intrafallopian device at the target location during withdrawal of elongate body 52, as'described regarding Fig. 4. As the distal end of the primary coil is released, the distal loop forms a distal anchor bend 90. Similarly, the proximal loop forms a proximal anchor bend 92. Intermediate loops are restrained within the narrow target region 84, exerting substantial anchoring forces against the walls of the fallopian tube. As seen in Fig. 6, the loops need not assume their relaxed form to provide effective distal or proximal anchors.
The present invention further encompasses permanent sterilization by passing a current through the shaft to the intrafallopian device after elongate body 52 has been partially withdrawn, but before the intrafallopian device is fully released. Fallopian tube tissue in contact with the intrafallopian device is dessechated, and thus attached to the present intrafallopian device. This action also causes permanent tubal damage, leading to the formation of scar tissue which encapsulates the intrafallopian device and causes permanent occlusion of the tubal lumen. Clearly, the resilient member/shaft interface must be conductive to allow the present non-surgical method of permanent sterilization.
In conclusion, the present invention provides a contraceptive intrafallopian device which may be positioned without surgery. While the above is a complete description of the preferred embodiments of the invention, various alternatives, modifications, and equivalents may be used. For example, a wide variety of secondary shapes, including open loops, continuous bends, sinusoidal curves, or the like, may be imposed on the primary coil. Therefore, the above description should not be taken as limiting the scope of the invention, which is defined instead solely by the appended claims.
Although the present contraceptive method may be included within a group of contraceptive techniques generally referred to as fallopian tube occlusion methods, the present invention does not necessarily rely solely on blocking the fallopian tube to prevent fertilization. Instead, contraception is apparently provided by disrupting of ovum transport, the process of fertilization, and/or cleavage of the ovum. While the effect that copper has on these processes is not fully understood, it does appear that copper intrafallopian devices offer potentially significant increases in effectiveness over intrafallopian devices formed of other materials. Optionally, the present invention further encompasses devices which promote tissue growth within the tube to induce tubal occlusion, further inhibiting conception.
The present invention is anchored within the isthmus of the fallopian tube, overcoming the unintended expulsion of the device and the resulting failure of the contraceptive method. Such intrafallopian device expulsion has been the single greatest factor limiting the efficacy of easily positioned intrafallopian contraceptive techniques.
The present intrafallopian devices are generally elongate resilient structures pre-formed into secondary shapes. These secondary shapes will bias the resilient structure so as to provide strong forces against the lumen wall of the fallopian tube. Clearly, the secondary shape must have a larger outer diameter than the inner diameter of the fallopian tube.
Conveniently, the present resilient structures are insertable into a catheter, the catheter wall restraining the resilient structure in a straight configuration. As the resilient structure has an outer diameter when in the straight configuration which is less than the inner diameter of the fallopian tube, the catheter containing the present intrafallopian device is easily transcervically introduced.
Moreover, the device is readily removed by snaring the resilient structure near the proximal end and pulling proximally on the resilient structure, thereby straightening the resilient structure and allowing it to be withdrawn without injuring the fallopian tube. Alternatively, an electrical current is applied to the device after it is at least partially releasing the fallopian tube, providing permanent sterilization.
Referring now to Fig. 1, a first embodiment of the present contraceptive intrafallopian device 10 is formed from a resilient primary coil 12. Primary coil 12 is most easily originally formed as a straight cylindrical coil or spring, preferably having an outer diameter in the range from .2 mm to 5 mm, and having a length in the range from 20 mm to 150 mm.
Ideally, primary coil 12 has an outer diameter in the range from .4 mm to 2 mm and a length in the range from 30 mm to 70 mm. The straight primary coil may then be bent into a variety of secondary shapes.
The primary coil 12 of intrafallopian device 10 includes a proximal end 14 and a distal end 16. Between these ends, three loops 20 are formed, each having an inner diameter 22. Located between loops 20 are straight sections 24, which increase the overall cross-section of the intrafallopian device to an overall width 26. Preferably, inner diameter 22 is in the range from 2 mm to 10 mm, while overall width 26 is at least 6mm, ideally being in the range from 8 mm to 40 mm. Distal and proximal ends 14, 16 each include an atraumatic endcap 18 to prevent injury to the fallopian tube.
Preferably, primary coil 12 is formed from a beryllium copper alloy wire. Beryllium copper provides the resilience necessary to avoid expulsion of the device, and also provides the increased effectiveness of a copper contraceptive intrafallopian device. Alternatively, primary coil 12 is formed from a resilient metal, such as stainless steel, platinum, a shape memory alloy, or the like. If such materials are used, primary coil 12 is preferably plated with copper or a copper alloy or otherwise has copper attached.
5 To further reduce the possibility of expulsion of intrafallopian device 10, fibers are optionally carried on primary coil 12. The fibers may be short individual fibers, or may alternatively be wound into primary coil 12.
Preferably, the fibers comprise copper, thereby increasing the 10 total copper surface area. Such copper fibers are preferably bonded to primary coil 12 with solder, brazing, a polymeric adhesive, or the like. Alternatively, polyester fibers such as DacronT", Rayon, or the like, are bonded to the surface of primary coil 12 using a polymeric adhesive. The polyester fibers promote increased tissue growth around the coil, thus further reducing the possibility of expulsion of the device from the fallopian tube.
A secondary shape has been superimposed on the primary coil to form intrafallopian device 10, the secondary shape comprising loops 20 separated by straight sections 24.
This secondary shape is herein referred to as a "flower coil."
The flower coil shape is particularly advantageous in that outer diameter 26 is substantially larger than the primary coil diameter, while the individual loops 20 have relatively small inner diameters 22 which will maintain the largest possible anchoring force against the fallopian tube.
Minimizing inner diameter 22 also ensures that anchoring force is applied within the fallopian tube, despite the curvature of the fallopian tube.
Referring now to Fig. 2, an alternative embodiment of the present contraceptive intrafallopian device 30 includes additional loops to ensure anchoring of the device within the fallopian tube. Alternative embodiment 30 is formed from an =
elongate primary coil 32 having a proximal end 34 and a distal end (not shown). Elongate primary coil 32 has an outer diameter 36 which is smaller than the isthmus of the fallopian tube, allowing the straightened intrafallopian device to be inserted easily. Elongate primary coil 32 has been bent to form a secondary shape including a larger number of loops 38 than the embodiment of Fig. 1. Loops 38 have an outer diameter 40 which is larger than the inner diameter of the fallopian tube, preventing loops 38 from assuming their relaxed shape. Loops 38 are again separated by straight sections 42 of elongate primary coil 32, increasing the " overall intrafallopian device diameter 44.
In both embodiments of the present intrafallopian device 10, 30, at least one loop adjacent to the proximal end is disposed proximally of the narrowest portion of the fallopian tube, referred to as the isthmus. Similarly, at least one loop of the intrafallopian device is disposed distally of the isthmus. These proximal and distal loops act as anchors, helping to prevent proximal or distal movement of the intrafallopian device. In the embodiment of Fig. 2, at least one loop is also disposed adjacent to the isthmus of the fallopian tube, further helping to prevent unintentional expulsion.
Alternative intrafallopian device 30 may be positioned with multiple loops acting as proximal or distal anchors, or may alternatively have all but the proximal and distal anchor loops disposed along the fallopian tube to act as anchors within the lumen of that body. Advantageously, the embodiment of Fig. 2 is therefore less sensitive to variations in total fallopian tube length.
Referring now to Fig. 3, a delivery catheter for the present intrafallopian device comprises an elongate body 52 and a shaft 54. Elongate body 52 includes a lumen 56 in which shaft 54 is disposed, shaft 54 being slidable in the axial direction. Shaft 54 includes a core 58 having a tapered distal end 60, allowing the device to navigate through tortuous bends while retaining the column strength required to advance the device. Core 58 extends proximally through elongate body 52, and is capable of transferring compressive forces through the elongate body. Core 58 is typically formed from stainless steel, a stainless alloy, or the like.
Disposed over distal end 60 of core 58 is pusher cap 62.
Pusher cap 62 provides a low friction, deformable end piece having a distal coil interface surface 64. Pusher cap 62 is preferably formed of a low friction polymer such as PTFE, or the like.
Intrafallopian delivery catheter 50 receives the present intrafallopian device within the distal end of lumen 56 of elongate body 52. Lumen 56 has an inner diameter which is slightly larger than outer diameter 36 of the primary ~
coil. The present intrafallopian device is therefore straightened to a straight configuration as it is loaded proximally into the distal end of lumen 56. Elongate body 52 is sufficiently strong to restrain the primary coil in the straight configuration, but must remain sufficiently flexible to allow maneuvering within the body lumen. Elongate body 52 is preferably formed from an inelastic, flexible material such as polyurethane, PET, or the like.
Referring now to Fig. 4, intrafallopian device 10 is released from delivery catheter 50 within the fallopian tube by holding shaft 54 while proximally withdrawing elongate body 52. Distal coil interface surface 64 engages the proximal end 14 of primary coil 12. Initially, primary coil 12 is restrained in a straight configuration by elongate body 52.
As elongate body 52 is withdrawn, primary coil 12 is released.
When primary coil 12 is unrestrained it forms loop 20; when released within the fallopian tube it will generally be restrained by the tubal wall in a configuration between straight and the relaxed secondary shape. Preferably, the first loop released will form a distal anchor bend 66.
Subsequent loops will bias primary coil 12 against the fallopian tube, and form a proximal anchor bend, in that order.
Use of the present contraceptive intrafallopian device will be described with reference to Figs. 5 and 6. A
uterine introducer canula 70 is inserted transcervically through a uterus 72 to the region of an ostium 74. Elongate body 52 is then extended distally from canula 70 into a fallopian tube 77, preferably guided under fluoroscopy.
Alternatively, a hysteroscope may be used in place of canula 70. Elongate body 52 is maneuvered using a guide wire 78 past an isthmus 80.
After elongate body 52 extends past isthmus 80, guide wire 78 is removed. An intrafallopian device according to the present invention is inserted in the proximal end of elongate body 52, the intrafallopian device being restrained in a straight configuration by the elongate body. The device is advanced distally using shaft 54, the shaft and elongate body forming delivery catheter 50 (Fig. 3). Delivery catheter 50 is axially positioned so that at least one loop of the intrafallopian device is within a target region 84 adjacent to isthmus 80. Preferably, at least one loop is distal of target region 84, and at least one loop is proximal of target region 84 to form the distal and proximal anchor bends of the implanted intrafallopian device.
Once delivery catheter 50 is properly positioned, elongate body 52 may be axially withdrawn. Shaft 54 axially restrains the intrafallopian device at the target location during withdrawal of elongate body 52, as'described regarding Fig. 4. As the distal end of the primary coil is released, the distal loop forms a distal anchor bend 90. Similarly, the proximal loop forms a proximal anchor bend 92. Intermediate loops are restrained within the narrow target region 84, exerting substantial anchoring forces against the walls of the fallopian tube. As seen in Fig. 6, the loops need not assume their relaxed form to provide effective distal or proximal anchors.
The present invention further encompasses permanent sterilization by passing a current through the shaft to the intrafallopian device after elongate body 52 has been partially withdrawn, but before the intrafallopian device is fully released. Fallopian tube tissue in contact with the intrafallopian device is dessechated, and thus attached to the present intrafallopian device. This action also causes permanent tubal damage, leading to the formation of scar tissue which encapsulates the intrafallopian device and causes permanent occlusion of the tubal lumen. Clearly, the resilient member/shaft interface must be conductive to allow the present non-surgical method of permanent sterilization.
In conclusion, the present invention provides a contraceptive intrafallopian device which may be positioned without surgery. While the above is a complete description of the preferred embodiments of the invention, various alternatives, modifications, and equivalents may be used. For example, a wide variety of secondary shapes, including open loops, continuous bends, sinusoidal curves, or the like, may be imposed on the primary coil. Therefore, the above description should not be taken as limiting the scope of the invention, which is defined instead solely by the appended claims.
Claims (66)
1. An intrafallopian contraceptive device comprising:
a pre-formed resilient structure having a proximal end and a distal end, the resilient structure comprising copper and having a first configuration and a second configuration, the resilient structure being biased to form at least one proximal anchor adjacent the proximal end and at least one distal anchor adjacent the distal end in the second configuration, the at least one distal anchor adapted for insertion through an isthmus of a fallopian tube in the first configuration and capable of anchoring against a tubal wall of the fallopian tube when released from the first configuration therein, the at least one proximal anchor and at least one distal anchor defining an isthmus-traversing region therebetween and; and fibres carried on the resilient structure, the fibres comprising polyester so as to promote tissue growth.
a pre-formed resilient structure having a proximal end and a distal end, the resilient structure comprising copper and having a first configuration and a second configuration, the resilient structure being biased to form at least one proximal anchor adjacent the proximal end and at least one distal anchor adjacent the distal end in the second configuration, the at least one distal anchor adapted for insertion through an isthmus of a fallopian tube in the first configuration and capable of anchoring against a tubal wall of the fallopian tube when released from the first configuration therein, the at least one proximal anchor and at least one distal anchor defining an isthmus-traversing region therebetween and; and fibres carried on the resilient structure, the fibres comprising polyester so as to promote tissue growth.
2. The intrafallopian contraceptive device of claim 1, wherein the resilient structure comprises a resilient primary coil.
3. The intrafallopian contraceptive device of claim 2, wherein the resilient primary coil comprises a material selected from the group consisting of beryllium, zinc, stainless steel, platinum, and shape memory alloy.
4. The intrafallopian contraceptive device of claim 3, wherein the resilient primary coil comprises an allow including beryllium and copper.
5. The intrafallopian contraceptive device of claim 2, wherein the resilient primary coil comprises an alloy including at least 75% copper.
6. The intrafallopian contraceptive device of claim 2, wherein the resilient primary coil comprises a plated layer of a material selected from the group containing copper and copper alloy.
7. The intrafallopian contraceptive device of claim 1, further comprising copper fibres carried on the resilient structure.
8. The intrafallopian contraceptive device of claim 1, wherein the resilient structure is restrainable in a straight configuration for insertion through the isthmus of the fallopian tube.
9. The intrafallopian contraceptive device of claim 8, wherein the resilient structure has an outer diameter in the range between .2mm and 5mm and a length in the range between 20mm and 150mm when in the straight configuration.
10. The intrafallopian contraceptive device of claim 8, wherein the resilient structure has a width of at least 3mm when in a relaxed state.
11. The intrafallopian contraceptive device of claim 1, wherein the device comprises at least three bends which form loops in the resilient structure when in a relaxed state.
12. The intrafallopian contraceptive device of claim 11, wherein the loops are separated by straight sections when in a relaxed state.
13. The intrafallopian contraceptive device of claim 12, wherein the isthmus-traversing region includes one of the plurality of bends.
14. The intrafallopian contraceptive device of claim 1, wherein the resilient structure comprises a primary coil having a primary coil diameter, wherein:
1) the primary coil comprises copper;
2) the primary coil forms a secondary shape when in a relaxed state, the secondary shape defining a plurality of bends and an overall width which is larger than the primary coil diameter; and 3) the primary coil is restrainable in a straight configuration for insertion into a fallopian tube, and the bends of the secondary shape are capable of imposing resilient anchoring forces against an inner surface of a tubal wall so as to avoid inadvertent expulsion of the primary coil from the fallopian tube.
1) the primary coil comprises copper;
2) the primary coil forms a secondary shape when in a relaxed state, the secondary shape defining a plurality of bends and an overall width which is larger than the primary coil diameter; and 3) the primary coil is restrainable in a straight configuration for insertion into a fallopian tube, and the bends of the secondary shape are capable of imposing resilient anchoring forces against an inner surface of a tubal wall so as to avoid inadvertent expulsion of the primary coil from the fallopian tube.
15. The intrafallopian contraceptive device of claim 14, wherein the primary coil comprises a material selected from the group consisting of beryllium, zinc, stainless steel, platinum, and shape memory alloy.
16. The intrafallopian contraceptive device of claim 14, wherein the primary coil comprises an alloy including beryllium and copper.
17. The intrafallopian contraceptive device of claim 14, further comprising fibres disposed on the resilient structure, the fibres comprising a material selected from the group containing copper and polyester.
18. The intrafallopian contraceptive device of claim 14, wherein the primary coil diameter is in the range between .2mm and 5mm.
19. The intrafallopian contraceptive device of claim 14, wherein the primary coil has a length in the range between 20mm and 150mm when in a straight configuration.
20. The intrafallopian contraceptive device of claim 14, wherein the overall width is at least 6mm.
21. The intrafallopian contraceptive device of claim 14, wherein each of the bends forms a loop in the primary coil.
22. The intrafallopian contraceptive device of claim 21, wherein the loops are separated by straight sections.
23. An intrafallopian contraceptive delivery system comprising:
an elongate body having a proximal end, a distal end, and a delivery lumen;
an intrafallopian contraceptive device of any one of claims 1-22 and slidably disposed within the elongate body;
the proximal and distal anchors of the device at the device capable of imposing resilient anchoring forces against an inner surface of a tubal wall proximally and distally of an isthmus of a fallopian tube, respectively, so as to avoid inadvertent expulsion of the device proximally and distally of the isthmus; and a shaft slidably disposed within the delivery lumen of the elongate body proximally of the device, the shaft having an interface surface near the distal end;
wherein the elongate body radially restrains the device in a straight configuration, and the device maybe released by axially restraining the device against the interface surface while proximally withdrawing the elongate body.
an elongate body having a proximal end, a distal end, and a delivery lumen;
an intrafallopian contraceptive device of any one of claims 1-22 and slidably disposed within the elongate body;
the proximal and distal anchors of the device at the device capable of imposing resilient anchoring forces against an inner surface of a tubal wall proximally and distally of an isthmus of a fallopian tube, respectively, so as to avoid inadvertent expulsion of the device proximally and distally of the isthmus; and a shaft slidably disposed within the delivery lumen of the elongate body proximally of the device, the shaft having an interface surface near the distal end;
wherein the elongate body radially restrains the device in a straight configuration, and the device maybe released by axially restraining the device against the interface surface while proximally withdrawing the elongate body.
24. The intrafallopian contraceptive delivery system of claim 23, wherein the shaft, the interface surface, and the device are electrically conductive so that the electrical current can be transmitted from a proximal end of the shaft to affix the device to a tubal wall of the fallopian tube.
25. An intrafallopian delivery system for transcervical introduction of a device, the delivery system comprising:
a first portion having an elongate body and a conductor for delivering tissue damaging energy, the first portion at least in part being sized to transcervically approach a fallopian tube;
a second portion detachably coupled to said elongate body, said second portion being sized to fit within a fallopian tube and being detachable from said elongate body to remain permanently within said fallopian tube, and wherein said tissue damaging energy causes a scar formation, in said fallopian tube, which attaches to said second portion.
a first portion having an elongate body and a conductor for delivering tissue damaging energy, the first portion at least in part being sized to transcervically approach a fallopian tube;
a second portion detachably coupled to said elongate body, said second portion being sized to fit within a fallopian tube and being detachable from said elongate body to remain permanently within said fallopian tube, and wherein said tissue damaging energy causes a scar formation, in said fallopian tube, which attaches to said second portion.
26. The delivery system of claim 25, wherein said tissue damaging energy comprises electrical energy, and wherein said conductor delivers electrical current.
27. The delivery system of claim 25, wherein said second portion is resilient and imposes an anchoring force against said fallopian tube.
28. The delivery system of claim 25, wherein said conductor is disposed within a lumen of said first portion's elongate body.
29. The delivery system of claim 25, wherein said tissue damaging energy is delivered before said second portion is detached from said elongate body.
30. The delivery system of claim 25, wherein said second portion has a first configuration prior to being detached and a second configuration after being detached.
31. The delivery system of claim 25, wherein said second portion has an outer diameter which is less than an initially size reduced inner diameter of said fallopian tube.
32. The delivery system of claim 25, wherein said second portion comprises a polymer material.
33. The delivery system of claim 25 further comprising an introducer through which said elongate body is inserted.
34. The delivery system of claim 25, wherein said second portion has a surface which attaches to said scar formation.
35. A device for inhibiting conception in a patient having a fallopian tube with an ostium and an adjacent tissue, the device comprising a body having a lumen with a fiberous polyester material carried at least in part by the body to facilitate tissue ingrowth into the body in a manner which provides permanent sterilization, the body insertable transcervically into the ostium of the fallopian tube and adapted to expand from a first configuration to a second configuration so as to be retained therein during tissue ingrowth into the fiberous polyester material.
36. The device of claim 35, wherein the body is elongate and the lumen is an axial lumen, and wherein the polyester fibers are disposed within the axial lumen of the elongate body.
37. The device of claim 35, wherein the body is elongate and the polyester fibers are laterally exposed about the elongate body.
38. The device of claim 35, wherein the body is expandable from a small diameter to a larger diameter so as to anchor the device during the tissue ingrowth and wherein the body is radially restrained in a delivery device before being delivered to the fallopian tube.
39. A tissue ingrowth contraceptive device for use in a fallopian tube having a tubal tissue, the contraceptive device comprising:
a tubular retention structure having a proximal end, a distal end, and an axis therebetween, the retention structure being axially flexible and insertable within the fallopian tube; and a material which can incite ingrowth of the tubal tissue therein, the ingrowth material attached to the retention structure.
a tubular retention structure having a proximal end, a distal end, and an axis therebetween, the retention structure being axially flexible and insertable within the fallopian tube; and a material which can incite ingrowth of the tubal tissue therein, the ingrowth material attached to the retention structure.
40. A contraceptive device for use in a fallopian tube having a tubal wall, the contraceptive device comprising:
a tubular retention structure having a proximal end, a distal end, and an axis therebetween, the retention structure expandable in situ from a narrow diameter configuration, the retention structure in the narrow configuration having a first diameter suitable for axial insertion into the fallopian tube, the expanded retention structure having a second diameter larger than the first diameter and adapted to engage the surrounding tubal wall and retain the contraceptive device within the fallopian tube.
a tubular retention structure having a proximal end, a distal end, and an axis therebetween, the retention structure expandable in situ from a narrow diameter configuration, the retention structure in the narrow configuration having a first diameter suitable for axial insertion into the fallopian tube, the expanded retention structure having a second diameter larger than the first diameter and adapted to engage the surrounding tubal wall and retain the contraceptive device within the fallopian tube.
41. The contraceptive device of claim 40, wherein the retention structure comprises a resilient helical coil.
42. The contraceptive device of claim 41, wherein the coil expands resiliently to safely engage the tubal wall throughout a range of tubal cross-sectional sizes.
43. The contraceptive device of claim 42, wherein the coil resiliently expands to open diameters throughout the range from about 0.10 to about 1.0 mm with an expansion force sufficient to help retain the contraceptive device in the fallopian tube and insufficient to penetrate through the tubal wall.
44. A contraceptive delivery system comprising:
an elongate body having a proximal end, a distal end, and a delivery lumen, the distal end configured for advancement into an ostium of a fallopian tube;
a shaft slidably disposed within the delivery lumen of the elongate body;
a resilient contraceptive device loadable within the delivery lumen of the distal end of the elongate body, the contraceptive device biased to anchor the contraceptive device within the fallopian tube upon release from the delivery lumen by retraction of the elongate body relative to the shaft; and fibers disposed along the contraceptive device, the fibers configured to assist in anchoring the contraceptive device within the fallopian tube.
an elongate body having a proximal end, a distal end, and a delivery lumen, the distal end configured for advancement into an ostium of a fallopian tube;
a shaft slidably disposed within the delivery lumen of the elongate body;
a resilient contraceptive device loadable within the delivery lumen of the distal end of the elongate body, the contraceptive device biased to anchor the contraceptive device within the fallopian tube upon release from the delivery lumen by retraction of the elongate body relative to the shaft; and fibers disposed along the contraceptive device, the fibers configured to assist in anchoring the contraceptive device within the fallopian tube.
45. The system of claim 44, wherein the contraceptive device comprises a coil having a proximal end and distal end and biased to form at least one bend therebetween, the at least one bend comprising at least one proximal anchor bend near the proximal end of the coil and at least one distal anchor bend near the distal end of the coil.
46. The system of claim 45, wherein the coil includes an isthmus-traversing region between the at least one proximal anchor bend and the at least one distal anchor bend, the length of the isthmus-traversing region sized to traverse an isthmus within the fallopian tube.
47. The system of claim 46, wherein the isthmus-traversing region includes a bend to assist in anchoring within the isthmus.
48. The system of claim 44, wherein the fibers comprise a polyester material.
49. The system of claim 44, wherein the fibers comprise copper.
50. The system of claim 44, wherein the contraceptive device comprises beryllium, zinc, stainless steel, platinum or a shape memory alloy.
51. The system of claim 44, wherein the shaft includes a core having a tapered distal end, the core configured to retain column strength during advancement of the elongate body into the ostium of the fallopian tube.
52. A device for inhibiting conception in a patient having a fallopian tube with an ostium and an adjacent tissue, the device comprising a body having a lumen with a fiberous material carried at least in part by the body to facilitate tissue ingrowth into the body in a manner which provides permanent sterilization, the body insertable transcervically into the ostium of the fallopian tube and adapted to expand from a first configuration to a second configuration so as to be retained therein during tissue ingrowth into the fiberous material.
53. The device of claim 52, wherein the body is elongate and the lumen is an axial lumen, and wherein the fiberous materials comprise fibers which are disposed within the axial lumen of the elongate body.
54. The device of claim 52, wherein the body is elongate and the fiberous material is laterally exposed about the elongate body.
55. The device of claim 52, wherein the body is expandable from a small diameter to a larger diameter so as to anchor the device during the tissue ingrowth.
56. The use of an intrafallopian implant for assembly of a delivery system for a transcervical sterilization procedure, said intrafallopian implant comprising a tubular structure with fibers coupled to said tubular structure, the fibers adapted to cause a tissue ingrowth.
57. The use of claim 56, wherein the intrafallopian implant additionally comprises anchors coupled to the tubular structure.
58. The use of claim 56, wherein the intrafallopian implant has a first non-expanded configuration and a second expanded configuration.
59. A system for providing permanent sterilization, the system comprising:
a flexible structure;
a plurality of fibers affixed to the structure, the fibers adapted to promote tissue ingrowth around the structure sufficient to provide permanent sterilization when disposed in a fallopian tube;
an elongate body having a proximal end and a distal end, the elongate body releasably supporting the flexible structure within the distal end; and a hysteroscope through which the distal end of the elongate body is extendible while the hysteroscope is inserted transcervically, the hysteroscope providing an image from within the uterus to direct the elongate body laterally toward an ostium of the fallopian tube.
a flexible structure;
a plurality of fibers affixed to the structure, the fibers adapted to promote tissue ingrowth around the structure sufficient to provide permanent sterilization when disposed in a fallopian tube;
an elongate body having a proximal end and a distal end, the elongate body releasably supporting the flexible structure within the distal end; and a hysteroscope through which the distal end of the elongate body is extendible while the hysteroscope is inserted transcervically, the hysteroscope providing an image from within the uterus to direct the elongate body laterally toward an ostium of the fallopian tube.
60. The system of claim 59, wherein the fibers induce tissue ingrowth when the flexible structure and fibers are advanced into the ostium and detached from the elongate body therein.
61. The system of claim 60, wherein the fibers comprise a polyester material.
62. The system of claim 60, wherein the structure has a first cross-section when supported by the elongate body and can define a second cross-section when deployed, the second cross-section being larger than the first cross-section.
63. Use of the intrafallopian contraceptive device of any one of claims 1-22 for permanent scar formation in the fallopian tube of a patient.
64. Use of the system of any one of claims 23-34, 44-51 and 59-62 for permanent scar formation in the fallopian tube of a patient.
65. Use of the device of any one of claims 35-43 and 52-55 for permanent scar formation in the fallopian tube of a patient.
66. The use of any one of claims 63-65, wherein the patient is sterilized.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/474,779 US6176240B1 (en) | 1995-06-07 | 1995-06-07 | Contraceptive transcervical fallopian tube occlusion devices and their delivery |
US08/474,779 | 1995-06-07 | ||
PCT/US1996/007483 WO1996040023A1 (en) | 1995-06-07 | 1996-05-21 | Contraceptive transcervical fallopian tube occlusion devices and their delivery |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2221332A1 CA2221332A1 (en) | 1996-12-19 |
CA2221332C true CA2221332C (en) | 2009-03-17 |
Family
ID=23884894
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002221332A Expired - Lifetime CA2221332C (en) | 1995-06-07 | 1996-05-21 | Contraceptive transcervical fallopian tube occlusion devices and their delivery |
Country Status (11)
Country | Link |
---|---|
US (10) | US6176240B1 (en) |
EP (1) | EP0957844B1 (en) |
JP (2) | JPH11506631A (en) |
AT (1) | ATE255866T1 (en) |
AU (1) | AU707047B2 (en) |
CA (1) | CA2221332C (en) |
DE (1) | DE69631069T2 (en) |
DK (1) | DK0957844T3 (en) |
ES (1) | ES2210370T3 (en) |
PT (1) | PT957844E (en) |
WO (1) | WO1996040023A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102949261A (en) * | 2012-10-25 | 2013-03-06 | 中国人民解放军第三军医大学第一附属医院 | Special-shaped anti-dropping seminiferous duct sterilization apparatus |
Families Citing this family (109)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6705323B1 (en) | 1995-06-07 | 2004-03-16 | Conceptus, Inc. | Contraceptive transcervical fallopian tube occlusion devices and methods |
US6176240B1 (en) * | 1995-06-07 | 2001-01-23 | Conceptus, Inc. | Contraceptive transcervical fallopian tube occlusion devices and their delivery |
US5885258A (en) * | 1996-02-23 | 1999-03-23 | Memory Medical Systems, Inc. | Medical instrument with slotted memory metal tube |
US20010041900A1 (en) * | 1999-12-21 | 2001-11-15 | Ovion, Inc. | Occluding device and method of use |
US7073504B2 (en) | 1996-12-18 | 2006-07-11 | Ams Research Corporation | Contraceptive system and method of use |
ES2238759T3 (en) | 1997-06-05 | 2005-09-01 | Adiana, Inc. | APPARATUS FOR THE OCLUSION OF THE UTERINE TRUMPS. |
US6200312B1 (en) | 1997-09-11 | 2001-03-13 | Vnus Medical Technologies, Inc. | Expandable vein ligator catheter having multiple electrode leads |
US6309384B1 (en) | 1999-02-01 | 2001-10-30 | Adiana, Inc. | Method and apparatus for tubal occlusion |
US8702727B1 (en) | 1999-02-01 | 2014-04-22 | Hologic, Inc. | Delivery catheter with implant ejection mechanism |
US6471635B1 (en) | 2000-02-10 | 2002-10-29 | Obtech Medical Ag | Anal incontinence disease treatment with controlled wireless energy supply |
US6482145B1 (en) | 2000-02-14 | 2002-11-19 | Obtech Medical Ag | Hydraulic anal incontinence treatment |
US6464628B1 (en) | 1999-08-12 | 2002-10-15 | Obtech Medical Ag | Mechanical anal incontinence |
US6709667B1 (en) | 1999-08-23 | 2004-03-23 | Conceptus, Inc. | Deployment actuation system for intrafallopian contraception |
ATE297172T1 (en) * | 1999-08-23 | 2005-06-15 | Conceptus Inc | ACTUATION SYSTEM FOR THE DEPLOYMENT OF A CONTRACEPTIVE IN THE FALLOW TUBE |
CN1286443C (en) | 1999-08-23 | 2006-11-29 | 孕体股份有限公司 | Insertion/deployment catheter system for intrafallopian contraception |
CN1698552B (en) | 2000-02-10 | 2010-05-12 | 厄罗洛吉卡股份公司 | Controlled urinary incontinence treatment |
WO2001047434A2 (en) | 2000-02-10 | 2001-07-05 | Potencia Medical Ag | Mechanical impotence treatment apparatus |
DE60136910D1 (en) | 2000-02-11 | 2009-01-22 | Potentica Ag | DEVICE WITH ENERGY CONVERSION DEVICES FOR IMPOTENA TREATMENT |
US7442165B2 (en) | 2000-02-14 | 2008-10-28 | Obtech Medical Ag | Penile prosthesis |
CA2397284C (en) | 2000-02-14 | 2010-05-18 | Potencia Medical Ag | Male impotence prosthesis apparatus with wireless energy supply |
US20050171569A1 (en) * | 2000-04-25 | 2005-08-04 | Impres Medical, Inc. | Method and apparatus for creating intrauterine adhesions |
US20050031662A1 (en) * | 2001-04-24 | 2005-02-10 | Impres Medical, Inc. | Bioreactive methods and devices for treating uterine bleeding |
CA2405710C (en) * | 2000-04-25 | 2010-04-20 | Impres Medical, Inc. | Method and apparatus for creating intrauterine adhesions |
US6605101B1 (en) | 2000-09-26 | 2003-08-12 | Microvention, Inc. | Microcoil vaso-occlusive device with multi-axis secondary configuration |
US7033374B2 (en) * | 2000-09-26 | 2006-04-25 | Microvention, Inc. | Microcoil vaso-occlusive device with multi-axis secondary configuration |
US7029486B2 (en) * | 2000-09-26 | 2006-04-18 | Microvention, Inc. | Microcoil vaso-occlusive device with multi-axis secondary configuration |
US7572288B2 (en) * | 2001-07-20 | 2009-08-11 | Microvention, Inc. | Aneurysm treatment device and method of use |
US8252040B2 (en) | 2001-07-20 | 2012-08-28 | Microvention, Inc. | Aneurysm treatment device and method of use |
US8715312B2 (en) * | 2001-07-20 | 2014-05-06 | Microvention, Inc. | Aneurysm treatment device and method of use |
EP1408847B1 (en) | 2001-07-26 | 2005-05-04 | Oregon Health Sciences University | Vessel closure member and delivery apparatus |
US6780182B2 (en) | 2002-05-23 | 2004-08-24 | Adiana, Inc. | Catheter placement detection system and operator interface |
US7087064B1 (en) * | 2002-10-15 | 2006-08-08 | Advanced Cardiovascular Systems, Inc. | Apparatuses and methods for heart valve repair |
US9149602B2 (en) | 2005-04-22 | 2015-10-06 | Advanced Cardiovascular Systems, Inc. | Dual needle delivery system |
US7485143B2 (en) * | 2002-11-15 | 2009-02-03 | Abbott Cardiovascular Systems Inc. | Apparatuses and methods for heart valve repair |
US8187324B2 (en) * | 2002-11-15 | 2012-05-29 | Advanced Cardiovascular Systems, Inc. | Telescoping apparatus for delivering and adjusting a medical device in a vessel |
US7404824B1 (en) * | 2002-11-15 | 2008-07-29 | Advanced Cardiovascular Systems, Inc. | Valve aptation assist device |
US7981152B1 (en) | 2004-12-10 | 2011-07-19 | Advanced Cardiovascular Systems, Inc. | Vascular delivery system for accessing and delivering devices into coronary sinus and other vascular sites |
AU2003297534A1 (en) * | 2002-12-24 | 2004-07-22 | Ovion, Inc. | Contraceptive device and delivery system |
WO2006028431A1 (en) * | 2003-05-21 | 2006-03-16 | Impres Medical, Inc. | Intrauterine implant and methods of use |
US7632291B2 (en) | 2003-06-13 | 2009-12-15 | Trivascular2, Inc. | Inflatable implant |
US20050061329A1 (en) * | 2003-09-18 | 2005-03-24 | Conceptus, Inc. | Catheter for intrafallopian contraceptive delivery |
US7998112B2 (en) | 2003-09-30 | 2011-08-16 | Abbott Cardiovascular Systems Inc. | Deflectable catheter assembly and method of making same |
KR101140039B1 (en) * | 2004-01-26 | 2012-05-02 | (주)아모레퍼시픽 | A composition that contains ginsenoside F1 and/or Compound K for skin external application |
EP1711143B1 (en) * | 2004-02-02 | 2013-04-10 | Conceptus, Inc. | Contraceptive with permeable and impermeable components |
CN101627938B (en) * | 2004-02-02 | 2011-12-21 | 孕体有限公司 | Contraceptive with permeable and impermeable components |
US8048101B2 (en) | 2004-02-25 | 2011-11-01 | Femasys Inc. | Methods and devices for conduit occlusion |
US8052669B2 (en) | 2004-02-25 | 2011-11-08 | Femasys Inc. | Methods and devices for delivery of compositions to conduits |
US8048086B2 (en) | 2004-02-25 | 2011-11-01 | Femasys Inc. | Methods and devices for conduit occlusion |
US9238127B2 (en) | 2004-02-25 | 2016-01-19 | Femasys Inc. | Methods and devices for delivering to conduit |
EP1740133A2 (en) * | 2004-04-28 | 2007-01-10 | AMS Research Corporation | Endoscopic delivery of medical devices |
US6964274B1 (en) * | 2004-06-07 | 2005-11-15 | Ethicon, Inc. | Tubal sterilization device having expanding electrodes and method for performing sterilization using the same |
US7250050B2 (en) | 2004-06-07 | 2007-07-31 | Ethicon, Inc. | Tubal sterilization device having sesquipolar electrodes and method for performing sterilization using the same |
WO2006052940A2 (en) * | 2004-11-05 | 2006-05-18 | Asthmatx, Inc. | Medical device with procedure improvement features |
CN102525591B (en) | 2005-01-25 | 2014-12-10 | 泰科医疗集团有限合伙公司 | Structures for permanent occlusion of a hollow anatomical structure |
US20070023534A1 (en) * | 2005-07-22 | 2007-02-01 | Mingsheng Liu | Water-source heat pump control system and method |
US20070088321A1 (en) * | 2005-09-30 | 2007-04-19 | Clast Trading Ltd | Use of bioabsorbable, biocompatible adhesives as a method of female contraception |
US8235047B2 (en) * | 2006-03-30 | 2012-08-07 | Conceptus, Inc. | Methods and devices for deployment into a lumen |
US8562628B2 (en) * | 2006-04-03 | 2013-10-22 | Conceptus, Inc. | Linear motion delivery system for female sterilization device |
US9017361B2 (en) | 2006-04-20 | 2015-04-28 | Covidien Lp | Occlusive implant and methods for hollow anatomical structure |
US7647930B2 (en) * | 2006-08-02 | 2010-01-19 | ProMed, Inc. | Fallopian tube occlusion devices and methods |
AU2007307639B2 (en) * | 2006-10-12 | 2013-03-21 | Aub Holdings Llc | Method and apparatus for occluding a lumen |
TWI330950B (en) * | 2006-10-27 | 2010-09-21 | Sunplus Technology Co Ltd | Sequential decoding method and apparatus thereof |
US20090036840A1 (en) * | 2006-11-22 | 2009-02-05 | Cytyc Corporation | Atraumatic ball tip and side wall opening |
US20100063360A1 (en) * | 2006-11-28 | 2010-03-11 | Adiana, Inc. | Side-arm Port Introducer |
WO2008111073A2 (en) | 2007-03-15 | 2008-09-18 | Bioprotect Ltd. | Prosthetic devices and methods for using same |
WO2008115922A1 (en) | 2007-03-19 | 2008-09-25 | Michael Brenzel | Methods and apparatus for occlusion of body lumens |
EP2162101B1 (en) * | 2007-06-25 | 2019-02-20 | MicroVention, Inc. | Self-expanding prosthesis |
EP2211768B1 (en) | 2007-10-11 | 2021-03-24 | Implantica Patent Ltd. | Apparatus for controlling flow in a bodily organ |
US8696543B2 (en) | 2007-10-11 | 2014-04-15 | Kirk Promotion Ltd. | Method for controlling flow of intestinal contents in a patient's intestines |
US10195325B2 (en) * | 2007-10-11 | 2019-02-05 | Peter Forsell | Method for controlling flow of sperms in a uterine tube |
US8992409B2 (en) | 2007-10-11 | 2015-03-31 | Peter Forsell | Method for controlling flow in a bodily organ |
WO2010042045A1 (en) | 2008-10-10 | 2010-04-15 | Milux Holding S.A. | A system, an apparatus, and a method for treating a sexual dysfunctional female patient |
US8795153B2 (en) | 2007-10-11 | 2014-08-05 | Peter Forsell | Method for treating female sexual dysfunction |
US20090125023A1 (en) * | 2007-11-13 | 2009-05-14 | Cytyc Corporation | Electrosurgical Instrument |
US8961448B2 (en) * | 2008-01-28 | 2015-02-24 | Peter Forsell | Implantable drainage device |
EP2240138B1 (en) | 2008-01-29 | 2021-07-21 | Implantica Patent Ltd. | Apparatus for treating obesity |
US20100006105A1 (en) * | 2008-07-08 | 2010-01-14 | Carter Phillip J | Apparatus and methods for occluding a fallopian tube |
JP5754736B2 (en) * | 2008-08-06 | 2015-07-29 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Vascular occlusion device with textured surface |
US9554826B2 (en) | 2008-10-03 | 2017-01-31 | Femasys, Inc. | Contrast agent injection system for sonographic imaging |
US10070888B2 (en) | 2008-10-03 | 2018-09-11 | Femasys, Inc. | Methods and devices for sonographic imaging |
EP2349096B1 (en) | 2008-10-10 | 2021-01-27 | MedicalTree Patent Ltd. | An improved artificial valve |
WO2010042032A1 (en) | 2008-10-10 | 2010-04-15 | Milux Holding S.A. | Fastening means for implantable medcial control assembly |
EP2349170B1 (en) | 2008-10-10 | 2023-09-27 | Implantica Patent Ltd. | Apparatus for the treatment of female sexual dysfunction |
US20110196484A1 (en) | 2008-10-10 | 2011-08-11 | Milux Holding Sa | Heart help method |
SI2349383T1 (en) | 2008-10-10 | 2022-02-28 | Medicaltree Patent Ltd. | Heart help device and system |
US20100114151A1 (en) * | 2008-10-27 | 2010-05-06 | Mujwid James R | Methods and devices for deployment into a lumen |
US8347887B2 (en) | 2008-12-23 | 2013-01-08 | Ams Research Corporation | Devices and methods for reversal of permanent sterilization |
US9949812B2 (en) | 2009-07-17 | 2018-04-24 | Peter Forsell | Vaginal operation method for the treatment of anal incontinence in women |
US10952836B2 (en) | 2009-07-17 | 2021-03-23 | Peter Forsell | Vaginal operation method for the treatment of urinary incontinence in women |
US8231619B2 (en) * | 2010-01-22 | 2012-07-31 | Cytyc Corporation | Sterilization device and method |
WO2011110177A1 (en) | 2010-03-09 | 2011-09-15 | Lina Medical Aps | Contraceptive device |
US8550086B2 (en) | 2010-05-04 | 2013-10-08 | Hologic, Inc. | Radiopaque implant |
EP2629721B1 (en) | 2010-10-18 | 2019-03-20 | Bioceptive, Inc. | Apparatus for inserting a device or pharmaceutical into a body cavity |
US10716624B2 (en) | 2011-05-05 | 2020-07-21 | Biolitec Unternehmensbeteiligungs Ii Ag | Minimally invasive contraception method and device |
WO2012155093A1 (en) | 2011-05-11 | 2012-11-15 | Microvention, Inc. | Device for occluding a lumen |
US9017366B2 (en) * | 2011-08-19 | 2015-04-28 | Empirilon Technology, Llc | Methods and systems for performing intralumenal procedures |
WO2013057566A2 (en) | 2011-10-18 | 2013-04-25 | Ortho-Space Ltd. | Prosthetic devices and methods for using same |
US9089418B2 (en) | 2012-08-14 | 2015-07-28 | Contramed, Llc | Intrauterine contraceptive device |
US9265652B2 (en) | 2012-08-14 | 2016-02-23 | Contramed, Llc | Intrauterine contraceptive device |
US10918516B2 (en) | 2013-10-14 | 2021-02-16 | Sebela Vlc Limited | Intrauterine device with controlled copper ion elution |
US10188546B2 (en) | 2013-10-14 | 2019-01-29 | Sebela Vlc Limited | Intrauterine device with controlled copper ion elution |
US9180040B2 (en) | 2013-10-18 | 2015-11-10 | Contramed, Llc | Intrauterine device with retrieval thread |
CN106102600B (en) * | 2014-02-27 | 2019-09-27 | 因库麦迪斯有限公司 | Embolism framework microcoils |
SI24779A (en) * | 2014-08-28 | 2016-02-29 | CABALLUS CARNIOLUS & AMSTERDAMUS, veterinarsko tehnološki center in trgovina, uvoz - izvoz d.o.o. | Intrauterine device for humans and animals and the process for producing the same |
US10307168B2 (en) | 2015-08-07 | 2019-06-04 | Terumo Corporation | Complex coil and manufacturing techniques |
WO2017046647A1 (en) | 2015-09-18 | 2017-03-23 | Ortho-Space Ltd. | Intramedullary fixated subacromial spacers |
EP3573806A4 (en) | 2017-01-30 | 2019-12-11 | Ortho-Space Ltd. | Processing machine and methods for processing dip-molded articles |
US11076982B2 (en) * | 2017-12-29 | 2021-08-03 | Gyrus Acmi, Inc. | Fallopian biocompatible plug with differently expandable portions |
WO2019211832A1 (en) * | 2018-04-30 | 2019-11-07 | Ocon Medical Ltd. | Localized delivery of an active agent |
Family Cites Families (262)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US29345A (en) * | 1860-07-24 | Martin shirk | ||
US2102270A (en) | 1935-11-29 | 1937-12-14 | Mortimer N Hyams | Electrosurgical device |
US2365296A (en) | 1943-06-15 | 1944-12-19 | Marie E Schimpf | Inflatable pessary |
US3042030A (en) | 1958-11-25 | 1962-07-03 | Read Thane | Spherical type insert plug for body passageway and tool therefor |
US3334629A (en) | 1964-11-09 | 1967-08-08 | Bertram D Cohn | Occlusive device for inferior vena cava |
US3422813A (en) | 1965-06-21 | 1969-01-21 | Dow Corning | Method for sterilization of males |
US3404682A (en) | 1965-11-17 | 1968-10-08 | Tassette Inc | Vaginal cup and means for inserting same |
US3405711A (en) | 1966-07-22 | 1968-10-15 | Maurice I. Bakunin | Intrauterine contraceptive device |
FR1565329A (en) * | 1967-04-04 | 1969-05-02 | ||
US3467090A (en) | 1967-05-03 | 1969-09-16 | Phillip B Zollett | Self-retaining occlusive stem pessary |
US3463141A (en) | 1967-05-15 | 1969-08-26 | Casimir Mozolf | Male contraceptive |
US3563235A (en) * | 1968-09-18 | 1971-02-16 | Searle & Co | Intrauterine contraceptive method |
US3803308A (en) | 1968-09-18 | 1974-04-09 | Searle & Co | Method of contraception with a soluble non-toxic copper or zinc compound |
US3598115A (en) | 1969-04-08 | 1971-08-10 | Herbert W Horne Jr | Intra-uterine contraceptive device |
US3675639A (en) | 1970-05-11 | 1972-07-11 | Hugo S Cimber | Device for and method of temporary sterilizing a female |
US3680542A (en) | 1970-05-11 | 1972-08-01 | Hugo S Cimber | Device for occlusion of an oviduct |
US3620212A (en) | 1970-06-15 | 1971-11-16 | Robert D Fannon Jr | Intrauterine contraceptive device |
US3675642A (en) | 1970-07-23 | 1972-07-11 | Peter Herent Lord | Rectal cone for use in postoperative treatment |
US3687129A (en) | 1970-10-02 | 1972-08-29 | Abcor Inc | Contraceptive device and method of employing same |
FR2110697A5 (en) | 1970-10-27 | 1972-06-02 | Rhone Poulenc Sa | |
US4040417A (en) | 1970-12-01 | 1977-08-09 | G. D. Searle & Co. | Intrauterine device |
US3722500A (en) | 1970-12-29 | 1973-03-27 | R Robinson | Abortive device and method |
US3760806A (en) * | 1971-01-13 | 1973-09-25 | Alza Corp | Helical osmotic dispenser with non-planar membrane |
US3858586A (en) * | 1971-03-11 | 1975-01-07 | Martin Lessen | Surgical method and electrode therefor |
NO136251C (en) | 1971-05-11 | 1977-08-10 | Sandoz Ag | ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE PYRIDAZINE DERIVATIVES. |
US3763856A (en) | 1971-11-19 | 1973-10-09 | T Blomberg | Inserter for intra-uterine contraceptive device |
US3768102A (en) | 1972-02-03 | 1973-10-30 | Univ Utah | Implantable artificial urethral valve |
US3840016A (en) | 1972-03-10 | 1974-10-08 | H Lindemann | Electrocoagulation-bougie for the intrauterine tube sterilization |
DE2220117C3 (en) | 1972-04-25 | 1975-01-09 | Bleier, Waldemar, Dr.Med., 6630 Saarlouis | Clip for long-term reversible or permanent interruption of express parents and vas deferens within the human or animal organism as well as instruments for setting the clip |
US3868956A (en) | 1972-06-05 | 1975-03-04 | Ralph J Alfidi | Vessel implantable appliance and method of implanting it |
JPS4967325A (en) * | 1972-10-31 | 1974-06-29 | ||
USRE29345E (en) | 1973-02-26 | 1977-08-09 | The Franklin Institute | Method and apparatus for non-surgical, reversible sterilization of females |
US3805767A (en) | 1973-02-26 | 1974-04-23 | Erb Rene | Method and apparatus for non-surgical, reversible sterilization of females |
US3858571A (en) * | 1973-07-02 | 1975-01-07 | Arthur I Rudolph | Cornual plug |
CA1018419A (en) * | 1973-07-04 | 1977-10-04 | Gerald Turp | Instrument for laparoscopic tubal cauterization |
US4111196A (en) * | 1973-07-27 | 1978-09-05 | Lionel C. R. Emmett | Intrauterine contraceptive device of c or omega form with tubular inserter and method of placement |
GB1465684A (en) | 1973-07-27 | 1977-02-23 | Emmett L | Contraceptive device |
US3895634A (en) * | 1973-10-18 | 1975-07-22 | Rapid American Corp | Tampon inserter |
US3918431A (en) | 1974-01-11 | 1975-11-11 | Manfred Sinnreich | Fallopian tube obturating device |
GB1460077A (en) | 1974-01-15 | 1976-12-31 | Brundin J O | Contraceptive device |
DE2404605A1 (en) | 1974-01-31 | 1975-08-07 | Brundin Jan Olof | Elongate intrauterine contraceptive element - has plug for each fallopian tube opening, joined by bridge element |
CH587664A5 (en) * | 1974-09-05 | 1977-05-13 | Fischer Fa F L | |
US4374523A (en) | 1974-10-29 | 1983-02-22 | Yoon In B | Occlusion ring applicator |
US3982542A (en) * | 1975-03-12 | 1976-09-28 | Ford John L | Electroresectroscope and method of laparoscopic tubal sterilization |
NL7504321A (en) | 1975-04-11 | 1976-10-13 | Philips Nv | DEVICE FOR STERILIZATION BY TRANSUTERINE TUBACOAGULATION. |
US4135495A (en) | 1975-05-21 | 1979-01-23 | Borgen Jennings O | Method and means for reversible sterilization |
DE2525650C3 (en) | 1975-06-09 | 1978-05-24 | B. Braun Melsungen Ag, 3508 Melsungen | Clamp for blocking fallopian tubes and vas deferens in the human and animal body |
US4136695A (en) | 1975-07-09 | 1979-01-30 | Gynetech-Denver, Inc. | Transvaginal sterilization instrument |
US4416660A (en) | 1975-07-09 | 1983-11-22 | Dafoe Charles A | Method of transvaginal sterilization |
AU509186B2 (en) | 1975-08-14 | 1980-04-24 | Vitek Inc. | Surgical implant |
DE2537620A1 (en) | 1975-08-23 | 1977-02-24 | Lothar Dr Med Popp | Balloon pessary for blocking fallopian tubes - is inflatable double balloon containing X:ray opaque thread in wall |
US4185618A (en) | 1976-01-05 | 1980-01-29 | Population Research, Inc. | Promotion of fibrous tissue growth in fallopian tubes for female sterilization |
US4085743A (en) * | 1976-03-02 | 1978-04-25 | In Bae Yoon | Multiple occlusion ring applicator and method |
FI54762C (en) | 1976-08-20 | 1979-03-12 | Em Set Oy | MEASUREMENT OF THE MEASUREMENT OF THE SHAFT WITH A HEADLAMP WITH A GUMMIPAOSE |
US4140126A (en) * | 1977-02-18 | 1979-02-20 | Choudhury M Hasan | Method for performing aneurysm repair |
NL7802043A (en) * | 1977-03-28 | 1978-10-02 | Ortho Pharma Corp | INSTRUMENT FOR THE INSERTION OF AN INTRA-UTERINE ANTI-CONCEPTION AGENT AND A METHOD FOR THE INSERTION OF AN INTRA-UTERINE ANTI-CONCEPTION AGENT. |
US4181725A (en) | 1977-05-02 | 1980-01-01 | The Regents Of The University Of Michigan | Method for alleviating psoriasis |
US4160446A (en) | 1977-08-12 | 1979-07-10 | Abcor, Inc. | Apparatus for and method of sterilization by the delivery of tubal-occluding polymer |
FR2409041A1 (en) | 1977-11-18 | 1979-06-15 | Wolf Gmbh Richard | FLEXIBLE PLIERS FOR CAPTURING AND POSITIONING TRUMP CLOSERS |
AU516751B2 (en) | 1978-01-18 | 1981-06-18 | Medline, A.B. | Device for temporary occlusion of body channels |
US4509504A (en) | 1978-01-18 | 1985-04-09 | Medline Ab | Occlusion of body channels |
DE2803685A1 (en) | 1978-01-27 | 1979-08-02 | Medline Ab | Temporarily or permanently effective contraceptive - comprises an acrylic! swellable, hydrogel plug for insertion in an oviduct or spermatic cord |
US4245623A (en) | 1978-06-06 | 1981-01-20 | Erb Robert A | Method and apparatus for the hysteroscopic non-surgical sterilization of females |
US4158050A (en) | 1978-06-15 | 1979-06-12 | International Fertility Research Programme | Method for effecting female sterilization without surgery |
US4207891A (en) * | 1978-10-10 | 1980-06-17 | Population Research Incorporated | Dispensing instrument with supported balloon |
NL7810696A (en) | 1978-10-26 | 1980-04-29 | Verschoof K J H | ANTI-CONCEPTION DEVICE AND DEVICES FOR THEIR APPLICATION. |
US4246896A (en) * | 1978-10-30 | 1981-01-27 | Dynatech Corp. | Intracervical cuff (ICC) for contraception and prevention of venereal disease and applicator therefor |
ES239677Y (en) | 1978-11-23 | 1979-06-16 | Sopena Quesada Angel | INTRAUTERINE SPERM |
GB2038186A (en) | 1978-12-21 | 1980-07-23 | S P F Pianificazione Della Fam | Contraceptive devices |
DE2913036C2 (en) | 1979-03-31 | 1983-10-20 | Lothar W. Dr.med. 2000 Hamburg Popp | Pessary for preventing pregnancy |
SE419597B (en) | 1979-05-04 | 1981-08-17 | Medline Ab | DEVICE FOR TEMPORARY OR PERMANENT CONNECTION OF BODY CHANNELS OR SPACES OF HUMAN AND ANIMALS |
US4485814A (en) | 1979-09-05 | 1984-12-04 | Yoon In B | One-piece compound elastic occluding member |
US4326511A (en) * | 1979-10-05 | 1982-04-27 | Zimerman Clota E | Intrauterine contraceptive device |
DE3267569D1 (en) | 1981-07-14 | 1986-01-02 | Cimber Hugo | Occlusive pessary |
FR2522959A1 (en) * | 1982-03-15 | 1983-09-16 | Hamou Jacques | Tubular pessary for reversible pregnancy protection - has soft central tubular section with proximal and distal loop of fibrous material |
SE445884B (en) * | 1982-04-30 | 1986-07-28 | Medinvent Sa | DEVICE FOR IMPLANTATION OF A RODFORM PROTECTION |
US4537186A (en) | 1982-05-17 | 1985-08-27 | Verschoof Karel J H | Contraceptive device |
AU1914583A (en) | 1982-09-30 | 1984-04-05 | Hodgson, D.E. | Expandable plug for tubular occlusion suitable for contraception |
US4638803A (en) | 1982-09-30 | 1987-01-27 | Rand Robert W | Medical apparatus for inducing scar tissue formation in a body |
US4523590A (en) * | 1982-10-25 | 1985-06-18 | Wilfred Roth | Method and device for reversible sterilization in mammals |
ATE23106T1 (en) | 1983-01-20 | 1986-11-15 | Cimber Hugo | OCCLUSIVE ESSARY. |
US4503569A (en) * | 1983-03-03 | 1985-03-12 | Dotter Charles T | Transluminally placed expandable graft prosthesis |
US4619247A (en) * | 1983-03-31 | 1986-10-28 | Sumitomo Electric Industries, Ltd. | Catheter |
GB2150439A (en) | 1983-07-06 | 1985-07-03 | El Madani Hassan | An intra-uterine contraceptive device |
US4727866A (en) | 1984-01-23 | 1988-03-01 | Ortho Pharmaceutical (Canada) Ltd. | Intrauterine device detection and removal system |
US4572162A (en) * | 1984-01-23 | 1986-02-25 | Ortho Pharmaceutical (Canada) Ltd. | Method for the detection, location and extraction of an intrauterine device |
CA1295796C (en) | 1984-03-27 | 1992-02-18 | Conrad Whyne | Biodegradable matrix and methods for producing same |
US4601698A (en) | 1984-09-17 | 1986-07-22 | Moulding Jr Thomas S | Method of and instrument for injecting a fluid into a uterine cavity and for dispersing the fluid into the fallopian tubes |
DE3434207C1 (en) * | 1984-09-18 | 1985-11-14 | Karl-Heinz Dr. 8703 Ochsenfurt Lurz | Variable intrauterine device and contraceptive device |
US4574806A (en) * | 1984-10-01 | 1986-03-11 | Cordis Corporation | Tunnelling device for peripheral vascular reconstruction |
EP0183372A1 (en) | 1984-10-19 | 1986-06-04 | RAYCHEM CORPORATION (a Delaware corporation) | Prosthetic stent |
US4606336A (en) | 1984-11-23 | 1986-08-19 | Zeluff James W | Method and apparatus for non-surgically sterilizing female reproductive organs |
EP0208653B1 (en) | 1985-07-11 | 1989-08-30 | Cimber, Hugo, Dr. med. | Occlusive pessary |
US4805618A (en) | 1985-08-08 | 1989-02-21 | Olympus Optical Co., Ltd. | Oviduct closing apparatus |
US4700701A (en) | 1985-10-23 | 1987-10-20 | Montaldi David H | Sterilization method and apparatus |
US4733665C2 (en) * | 1985-11-07 | 2002-01-29 | Expandable Grafts Partnership | Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft |
IN166447B (en) | 1985-11-27 | 1990-05-12 | Ethicon Inc | |
CS255758B1 (en) | 1985-12-11 | 1988-03-15 | Frantisek Rypacek | Preparat for the diagnostic of transportion function of oviduct and process for preparing thereof |
NL8600929A (en) | 1986-04-11 | 1987-11-02 | Fundatech Sa | METHOD FOR MANUFACTURING MEDICATED DISPOSABLE PESSARIES AND MEDICATED DISPOSABLE PESSARIES |
US4846834A (en) * | 1986-05-27 | 1989-07-11 | Clemson University | Method for promoting tissue adhesion to soft tissue implants |
US4824434A (en) | 1987-01-14 | 1989-04-25 | Seitz Jr H Michael | Apparatus used in a method for removing tissue and living organisms from human body cavities |
US4731052A (en) | 1987-01-14 | 1988-03-15 | Seitz Jr H Michael | Method for removing tissue and living organisms |
US4821741A (en) * | 1987-04-10 | 1989-04-18 | Mohajer Reza S | Barrier contraceptive |
US4788966A (en) | 1987-05-14 | 1988-12-06 | Inbae Yoon | Plug for use in a reversible sterilization procedure |
HU200554B (en) | 1987-06-01 | 1990-07-28 | Kalman Patai | Intra-uterine contraceptive device |
US4943290A (en) | 1987-06-23 | 1990-07-24 | Concept Inc. | Electrolyte purging electrode tip |
US4969458A (en) | 1987-07-06 | 1990-11-13 | Medtronic, Inc. | Intracoronary stent and method of simultaneous angioplasty and stent implant |
US5222978A (en) * | 1987-08-26 | 1993-06-29 | United States Surgical Corporation | Packaged synthetic absorbable surgical elements |
GB2211095B (en) | 1987-10-19 | 1991-09-11 | Anthony D Haeri | Device for contraception or sterilisation |
GB2212201B (en) | 1987-11-10 | 1992-06-03 | Donn Casey | Surgical clip |
US5259836A (en) | 1987-11-30 | 1993-11-09 | Cook Group, Incorporated | Hysterography device and method |
US4912595A (en) * | 1988-06-20 | 1990-03-27 | Kabushiki Kaisha Route Six | Simple high tension capacitor |
US5749915A (en) * | 1988-08-24 | 1998-05-12 | Focal, Inc. | Polymeric endoluminal paving process |
US4994069A (en) | 1988-11-02 | 1991-02-19 | Target Therapeutics | Vaso-occlusion coil and method |
FR2641692A1 (en) * | 1989-01-17 | 1990-07-20 | Nippon Zeon Co | Plug for closing an opening for a medical application, and device for the closure plug making use thereof |
US4932421A (en) | 1989-01-23 | 1990-06-12 | Steven Kaali | Electrified intrauterine device |
CH678393A5 (en) | 1989-01-26 | 1991-09-13 | Ulrich Prof Dr Med Sigwart | |
US5163958A (en) | 1989-02-02 | 1992-11-17 | Cordis Corporation | Carbon coated tubular endoprosthesis |
US5306226A (en) | 1989-02-09 | 1994-04-26 | Salama Fouad A | Urinary control with inflatable seal and method of using same |
CN1047447A (en) | 1989-05-23 | 1990-12-05 | 杨西群 | Fallopian tube blockage embolus and installation system thereof |
US5116318A (en) | 1989-06-06 | 1992-05-26 | Cordis Corporation | Dilatation balloon within an elastic sleeve |
US4932422A (en) | 1989-06-12 | 1990-06-12 | Ragheb Gamal A | Contraceptive device |
SE8903099L (en) | 1989-09-19 | 1991-03-20 | Radi Medical Systems | EMBOLISERINGSLEDARE |
US5065751A (en) | 1990-01-03 | 1991-11-19 | Wolf Gerald L | Method and apparatus for reversibly occluding a biological tube |
US4983177A (en) | 1990-01-03 | 1991-01-08 | Wolf Gerald L | Method and apparatus for reversibly occluding a biological tube |
US5095917A (en) | 1990-01-19 | 1992-03-17 | Vancaillie Thierry G | Transuterine sterilization apparatus and method |
US5133709A (en) | 1990-02-23 | 1992-07-28 | Prince Martin R | Optical fiber with atraumatic rounded end for use in laser angioplasty |
US5569245A (en) | 1990-03-13 | 1996-10-29 | The Regents Of The University Of California | Detachable endovascular occlusion device activated by alternating electric current |
US5122136A (en) * | 1990-03-13 | 1992-06-16 | The Regents Of The University Of California | Endovascular electrolytically detachable guidewire tip for the electroformation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas |
US5354295A (en) * | 1990-03-13 | 1994-10-11 | Target Therapeutics, Inc. | In an endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas |
US5897551A (en) | 1990-03-23 | 1999-04-27 | Myriadlase, Inc. | Medical device for applying high energy light and heat for gynecological sterilization procedures |
US5147353A (en) * | 1990-03-23 | 1992-09-15 | Myriadlase, Inc. | Medical method for applying high energy light and heat for gynecological sterilization procedures |
US5071407A (en) | 1990-04-12 | 1991-12-10 | Schneider (U.S.A.) Inc. | Radially expandable fixation member |
US5122137A (en) | 1990-04-27 | 1992-06-16 | Boston Scientific Corporation | Temperature controlled rf coagulation |
ATE113581T1 (en) * | 1990-05-04 | 1994-11-15 | Ciba Geigy Ag | SUBSTITUTED INDOLES. |
US5364393A (en) | 1990-07-02 | 1994-11-15 | Heart Technology, Inc. | Tissue dissipative recanalization catheter |
CA2060067A1 (en) * | 1991-01-28 | 1992-07-29 | Lilip Lau | Stent delivery system |
US5108420A (en) * | 1991-02-01 | 1992-04-28 | Temple University | Aperture occlusion device |
US5197978B1 (en) * | 1991-04-26 | 1996-05-28 | Advanced Coronary Tech | Removable heat-recoverable tissue supporting device |
EP0766533A1 (en) * | 1991-05-17 | 1997-04-09 | InnerDyne, Inc. | Method and device for thermal ablation |
US5147370A (en) | 1991-06-12 | 1992-09-15 | Mcnamara Thomas O | Nitinol stent for hollow body conduits |
US5474089A (en) | 1991-06-26 | 1995-12-12 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Method and device for reversible sterilization |
US5304194A (en) * | 1991-10-02 | 1994-04-19 | Target Therapeutics | Vasoocclusion coil with attached fibrous element(s) |
US5226911A (en) | 1991-10-02 | 1993-07-13 | Target Therapeutics | Vasoocclusion coil with attached fibrous element(s) |
US5354309A (en) | 1991-10-11 | 1994-10-11 | Angiomed Ag | Apparatus for widening a stenosis in a body cavity |
US5389100A (en) | 1991-11-06 | 1995-02-14 | Imagyn Medical, Inc. | Controller for manipulation of instruments within a catheter |
US5346498A (en) | 1991-11-06 | 1994-09-13 | Imagyn Medical, Inc. | Controller for manipulation of instruments within a catheter |
US5195964A (en) * | 1991-12-05 | 1993-03-23 | Research And Education Institute, Inc. | Transcervical catheterization cannula |
US5176692A (en) | 1991-12-09 | 1993-01-05 | Wilk Peter J | Method and surgical instrument for repairing hernia |
US5261916A (en) * | 1991-12-12 | 1993-11-16 | Target Therapeutics | Detachable pusher-vasoocclusive coil assembly with interlocking ball and keyway coupling |
KR0137691B1 (en) * | 1991-12-12 | 1998-04-27 | 티. 엔겔슨 에릭 | Detachable pusher vasoocclusive coil assembly with interlocking coupling |
US5234437A (en) * | 1991-12-12 | 1993-08-10 | Target Therapeutics, Inc. | Detachable pusher-vasoocclusion coil assembly with threaded coupling |
CN1035541C (en) | 1991-12-14 | 1997-08-06 | 兰俊生 | Woman sterilization stopper |
US5259954A (en) | 1991-12-16 | 1993-11-09 | Sepratech, Inc. | Portable intravenous solution preparation apparatus and method |
US5222964A (en) * | 1992-03-03 | 1993-06-29 | Cooper William I | Intraluminal stent |
US5207684A (en) | 1992-04-13 | 1993-05-04 | Neuro Navigational Corporation | Sheath for shunt placement for hydrocephalus |
US5303719A (en) * | 1992-08-14 | 1994-04-19 | Wilk Peter J | Surgical method and associated instrument assembly |
US5382261A (en) | 1992-09-01 | 1995-01-17 | Expandable Grafts Partnership | Method and apparatus for occluding vessels |
US5254132A (en) | 1992-09-01 | 1993-10-19 | Medlogic, Inc. | Methods for treating suturable wounds by use of sutures and cyanoacrylate adhesives |
US5469867A (en) | 1992-09-02 | 1995-11-28 | Landec Corporation | Cast-in place thermoplastic channel occluder |
IL106946A0 (en) | 1992-09-22 | 1993-12-28 | Target Therapeutics Inc | Detachable embolic coil assembly |
US5356388A (en) | 1992-09-22 | 1994-10-18 | Target Therapeutics, Inc. | Perfusion catheter system |
US5350397A (en) | 1992-11-13 | 1994-09-27 | Target Therapeutics, Inc. | Axially detachable embolic coil assembly |
US5250071A (en) * | 1992-09-22 | 1993-10-05 | Target Therapeutics, Inc. | Detachable embolic coil assembly using interlocking clasps and method of use |
US5312415A (en) * | 1992-09-22 | 1994-05-17 | Target Therapeutics, Inc. | Assembly for placement of embolic coils using frictional placement |
US5389089A (en) * | 1992-10-13 | 1995-02-14 | Imagyn Medical, Inc. | Catheter with angled ball tip for fallopian tube access and method |
US5382259A (en) * | 1992-10-26 | 1995-01-17 | Target Therapeutics, Inc. | Vasoocclusion coil with attached tubular woven or braided fibrous covering |
US5382260A (en) * | 1992-10-30 | 1995-01-17 | Interventional Therapeutics Corp. | Embolization device and apparatus including an introducer cartridge and method for delivering the same |
US5690666A (en) * | 1992-11-18 | 1997-11-25 | Target Therapeutics, Inc. | Ultrasoft embolism coils and process for using them |
JPH08500273A (en) * | 1992-11-19 | 1996-01-16 | ターゲット セラピューティクス,インコーポレイテッド | Large diameter vasoocclusive coil |
US5342348A (en) * | 1992-12-04 | 1994-08-30 | Kaplan Aaron V | Method and device for treating and enlarging body lumens |
US5330483A (en) * | 1992-12-18 | 1994-07-19 | Advanced Surgical Inc. | Specimen reduction device |
US5423849A (en) | 1993-01-15 | 1995-06-13 | Target Therapeutics, Inc. | Vasoocclusion device containing radiopaque fibers |
US5377668A (en) * | 1993-04-12 | 1995-01-03 | Optimed Technologies, Inc. | Apparatus and method for endoscopic diagnostics and therapy |
US5925059A (en) * | 1993-04-19 | 1999-07-20 | Target Therapeutics, Inc. | Detachable embolic coil assembly |
AU3886893A (en) | 1993-04-23 | 1994-11-21 | Bohdan Babinec | Method, device and apparatus for reversible contraceptive sterilization |
DE69412474T2 (en) | 1993-04-28 | 1998-12-17 | Focal Inc | DEVICE, PRODUCT AND USE REGARDING INTRALUMINAL PHOTOTHERMO MOLDING |
IL105828A (en) | 1993-05-28 | 1999-06-20 | Medinol Ltd | Medical stent |
US5411549A (en) * | 1993-07-13 | 1995-05-02 | Scimed Life Systems, Inc. | Selectively expandable, retractable and removable stent |
US5624449A (en) * | 1993-11-03 | 1997-04-29 | Target Therapeutics | Electrolytically severable joint for endovascular embolic devices |
US5423829A (en) | 1993-11-03 | 1995-06-13 | Target Therapeutics, Inc. | Electrolytically severable joint for endovascular embolic devices |
EP0740533A4 (en) | 1994-01-18 | 1998-01-14 | Endovascular Inc | Apparatus and method for venous ligation |
NL9400436A (en) | 1994-03-18 | 1995-11-01 | Benedict Marie Doorschodt | Fallopian tube blocking device and blocking assembly. |
US5746692A (en) * | 1994-05-05 | 1998-05-05 | Imagen Medical, Inc. | Catheter and endoscope system with distal protruding ball tip and method |
US5807236A (en) | 1994-05-05 | 1998-09-15 | Imagyn Medical Inc. | Catheter with guidewire and rounded enlargement and method |
US5499995C1 (en) | 1994-05-25 | 2002-03-12 | Paul S Teirstein | Body passageway closure apparatus and method of use |
ES1028231Y (en) | 1994-06-07 | 1995-05-16 | Marcus Hospital Supplies S A | INTRAUTERINE DEVICE. |
US5549624A (en) * | 1994-06-24 | 1996-08-27 | Target Therapeutics, Inc. | Fibered vasooclusion coils |
US5522836A (en) | 1994-06-27 | 1996-06-04 | Target Therapeutics, Inc. | Electrolytically severable coil assembly with movable detachment point |
US5458636A (en) | 1994-07-20 | 1995-10-17 | U.S. Biomaterials Corporation | Prosthetic device for repair and replacement of fibrous connective tissue |
US5876398A (en) * | 1994-09-08 | 1999-03-02 | Medtronic, Inc. | Method and apparatus for R-F ablation |
US5545210A (en) | 1994-09-22 | 1996-08-13 | Advanced Coronary Technology, Inc. | Method of implanting a permanent shape memory alloy stent |
PT702944E (en) | 1994-09-26 | 2000-06-30 | Hugo Cimber Dr Med | EXCLUSIVE PRESSURE |
US5562654A (en) | 1994-10-28 | 1996-10-08 | University Of Kentucky Research Foundation | Time-released delivery system |
US5895749A (en) * | 1994-10-31 | 1999-04-20 | Beth Israel Deaconess Medical Center | Male fertility and contraception home test kits |
US5578074A (en) | 1994-12-22 | 1996-11-26 | Target Therapeutics, Inc. | Implant delivery method and assembly |
IL116561A0 (en) * | 1994-12-30 | 1996-03-31 | Target Therapeutics Inc | Severable joint for detachable devices placed within the body |
US5630797A (en) * | 1995-01-17 | 1997-05-20 | Imagyn Medical, Inc. | Everting catheter system and method of utilizing the same |
US5514176A (en) | 1995-01-20 | 1996-05-07 | Vance Products Inc. | Pull apart coil stent |
US5537300A (en) * | 1995-02-01 | 1996-07-16 | Kraco Enterprises, Inc. | Control panel |
DE19508805C2 (en) * | 1995-03-06 | 2000-03-30 | Lutz Freitag | Stent for placement in a body tube with a flexible support structure made of at least two wires with different shape memory functions |
EP0734697B1 (en) * | 1995-03-30 | 2002-10-30 | Boston Scientific Limited | System for the implantation of liquid coils with secondary shape |
US6638291B1 (en) * | 1995-04-20 | 2003-10-28 | Micrus Corporation | Three dimensional, low friction vasoocclusive coil, and method of manufacture |
US6143007A (en) | 1995-04-28 | 2000-11-07 | Target Therapeutics, Inc. | Method for making an occlusive device |
US5639277A (en) * | 1995-04-28 | 1997-06-17 | Target Therapeutics, Inc. | Embolic coils with offset helical and twisted helical shapes |
US5534007A (en) | 1995-05-18 | 1996-07-09 | Scimed Life Systems, Inc. | Stent deployment catheter with collapsible sheath |
US5766160A (en) | 1995-06-06 | 1998-06-16 | Target Therapeutics, Inc. | Variable stiffness coils |
NO962336L (en) * | 1995-06-06 | 1996-12-09 | Target Therapeutics Inc | Vaso-occlusive spiral |
US5624461A (en) * | 1995-06-06 | 1997-04-29 | Target Therapeutics, Inc. | Three dimensional in-filling vaso-occlusive coils |
US6705323B1 (en) * | 1995-06-07 | 2004-03-16 | Conceptus, Inc. | Contraceptive transcervical fallopian tube occlusion devices and methods |
DE69638112D1 (en) | 1995-06-07 | 2010-02-25 | Conceptus Inc | Catheter system for electrically expandable transcervical occlusion devices for fallopian tube closure with mechanical attachment to the fallopian tube |
US6176240B1 (en) * | 1995-06-07 | 2001-01-23 | Conceptus, Inc. | Contraceptive transcervical fallopian tube occlusion devices and their delivery |
US5582619A (en) | 1995-06-30 | 1996-12-10 | Target Therapeutics, Inc. | Stretch resistant vaso-occlusive coils |
US5743905A (en) * | 1995-07-07 | 1998-04-28 | Target Therapeutics, Inc. | Partially insulated occlusion device |
US6019757A (en) * | 1995-07-07 | 2000-02-01 | Target Therapeutics, Inc. | Endoluminal electro-occlusion detection apparatus and method |
US5766203A (en) | 1995-07-20 | 1998-06-16 | Intelliwire, Inc. | Sheath with expandable distal extremity and balloon catheters and stents for use therewith and method |
US5601600A (en) * | 1995-09-08 | 1997-02-11 | Conceptus, Inc. | Endoluminal coil delivery system having a mechanical release mechanism |
US5690842A (en) | 1995-09-12 | 1997-11-25 | Zimmer, Inc. | Orthopaedic wire with an enlarged end and method of forming the same |
GB9519982D0 (en) | 1995-09-30 | 1995-12-06 | Magos Adam L | Device |
US6090063A (en) * | 1995-12-01 | 2000-07-18 | C. R. Bard, Inc. | Device, system and method for implantation of filaments and particles in the body |
US5843158A (en) | 1996-01-05 | 1998-12-01 | Medtronic, Inc. | Limited expansion endoluminal prostheses and methods for their use |
US6270495B1 (en) | 1996-02-22 | 2001-08-07 | Radiotherapeutics Corporation | Method and device for enhancing vessel occlusion |
US5582649A (en) * | 1996-02-29 | 1996-12-10 | The United States Of America As Represented By The Secretary Of The Air Force | Wafer transfer apparatus for use in a film deposition furnace |
US5649949A (en) * | 1996-03-14 | 1997-07-22 | Target Therapeutics, Inc. | Variable cross-section conical vasoocclusive coils |
AU2441397A (en) | 1996-04-05 | 1997-10-29 | Family Health International | Use of macrolide antibiotics for nonsurgical female sterilization and endometrial ablation |
US5792154A (en) * | 1996-04-10 | 1998-08-11 | Target Therapeutics, Inc. | Soft-ended fibered micro vaso-occlusive devices |
US6066139A (en) | 1996-05-14 | 2000-05-23 | Sherwood Services Ag | Apparatus and method for sterilization and embolization |
JP2000511890A (en) | 1996-05-16 | 2000-09-12 | ガイネティックス・インコーポレイテッド | Emergency contraception kit |
US5755773A (en) | 1996-06-04 | 1998-05-26 | Medtronic, Inc. | Endoluminal prosthetic bifurcation shunt |
WO1997049345A1 (en) | 1996-06-27 | 1997-12-31 | Chen Hank H | Transcervical electroocclusive sterilization device |
US5795288A (en) | 1996-08-08 | 1998-08-18 | Cohen; Kenneth L. | Apparatus with valve for treating incontinence |
US5858571A (en) * | 1996-08-30 | 1999-01-12 | Shin-Etsu Chemical Co., Ltd. | Method of producing hydrogen absorbing alloy powder, and electrode using hydrogen absorbing alloy powder produced by said method |
US5772669A (en) | 1996-09-27 | 1998-06-30 | Scimed Life Systems, Inc. | Stent deployment catheter with retractable sheath |
US5968052A (en) | 1996-11-27 | 1999-10-19 | Scimed Life Systems Inc. | Pull back stent delivery system with pistol grip retraction handle |
US6096052A (en) | 1998-07-08 | 2000-08-01 | Ovion, Inc. | Occluding device and method of use |
US20010041900A1 (en) | 1999-12-21 | 2001-11-15 | Ovion, Inc. | Occluding device and method of use |
US7073504B2 (en) | 1996-12-18 | 2006-07-11 | Ams Research Corporation | Contraceptive system and method of use |
WO1998031308A1 (en) | 1997-01-21 | 1998-07-23 | The Penn State Research Foundation | Transcervical contraceptive platinum microcoil |
ES2238759T3 (en) | 1997-06-05 | 2005-09-01 | Adiana, Inc. | APPARATUS FOR THE OCLUSION OF THE UTERINE TRUMPS. |
US6042590A (en) | 1997-06-16 | 2000-03-28 | Novomedics, Llc | Apparatus and methods for fallopian tube occlusion |
US5935137A (en) * | 1997-07-18 | 1999-08-10 | Gynecare, Inc. | Tubular fallopian sterilization device |
US6401719B1 (en) | 1997-09-11 | 2002-06-11 | Vnus Medical Technologies, Inc. | Method of ligating hollow anatomical structures |
WO1999039649A1 (en) | 1998-02-10 | 1999-08-12 | Dubrul William R | Occlusion, anchoring, tensioning and flow direction apparatus and methods for use |
US6080152A (en) | 1998-06-05 | 2000-06-27 | Medical Scientific, Inc. | Electrosurgical instrument |
US5979446A (en) | 1998-10-22 | 1999-11-09 | Synergyn Technologies, Inc. | Removable fallopian tube plug and associated methods |
US6178354B1 (en) * | 1998-12-02 | 2001-01-23 | C. R. Bard, Inc. | Internal mechanism for displacing a slidable electrode |
US6309384B1 (en) | 1999-02-01 | 2001-10-30 | Adiana, Inc. | Method and apparatus for tubal occlusion |
US6286510B1 (en) | 1999-11-05 | 2001-09-11 | Terry L. Ray | Apparatus and method for preventing fluid transfer between an oviduct and a uterine cavity |
US6371118B1 (en) * | 2000-06-07 | 2002-04-16 | Terry L. Ray | Birth control apparatus |
CA2429551A1 (en) * | 2000-11-22 | 2002-05-30 | Shepherd Medical Company | Method and device for vas occlusion |
US6550480B2 (en) * | 2001-01-31 | 2003-04-22 | Numed/Tech Llc | Lumen occluders made from thermodynamic materials |
JP4383746B2 (en) * | 2001-05-29 | 2009-12-16 | マイクロベンション インコーポレイテッド | Method for producing inflatable thread-like embolic device |
US6599299B2 (en) | 2001-06-26 | 2003-07-29 | Leonard S. Schultz | Device and method for body lumen occlusion |
US6802825B2 (en) | 2001-07-03 | 2004-10-12 | Coopersurgical, Inc. | Access catheter apparatus for use in minimally invasive surgery and diagnostic procedures in the uterus and fallopian tubes |
EP1408847B1 (en) * | 2001-07-26 | 2005-05-04 | Oregon Health Sciences University | Vessel closure member and delivery apparatus |
US6758831B2 (en) | 2001-09-24 | 2004-07-06 | Ethicon, Inc. | Device and method for aligning with the tubal ostium |
US6780182B2 (en) * | 2002-05-23 | 2004-08-24 | Adiana, Inc. | Catheter placement detection system and operator interface |
US20040172051A1 (en) | 2003-02-28 | 2004-09-02 | Sundaram Ravikumar | Method and apparatus for tubal occlusion |
US8016869B2 (en) | 2003-03-26 | 2011-09-13 | Biosensors International Group, Ltd. | Guidewire-less stent delivery methods |
US20040202694A1 (en) | 2003-04-11 | 2004-10-14 | Vascular Control Systems, Inc. | Embolic occlusion of uterine arteries |
KR101200642B1 (en) * | 2003-06-27 | 2012-11-12 | 콘셉투스 인코포레이티드 | Methods and devices for occluding body lumens and/or for delivering therapeutic agents |
EP1711143B1 (en) | 2004-02-02 | 2013-04-10 | Conceptus, Inc. | Contraceptive with permeable and impermeable components |
-
1995
- 1995-06-07 US US08/474,779 patent/US6176240B1/en not_active Expired - Lifetime
-
1996
- 1996-05-21 AU AU59267/96A patent/AU707047B2/en not_active Expired
- 1996-05-21 WO PCT/US1996/007483 patent/WO1996040023A1/en active IP Right Grant
- 1996-05-21 PT PT96916559T patent/PT957844E/en unknown
- 1996-05-21 AT AT96916559T patent/ATE255866T1/en not_active IP Right Cessation
- 1996-05-21 JP JP9500678A patent/JPH11506631A/en active Pending
- 1996-05-21 ES ES96916559T patent/ES2210370T3/en not_active Expired - Lifetime
- 1996-05-21 CA CA002221332A patent/CA2221332C/en not_active Expired - Lifetime
- 1996-05-21 EP EP96916559A patent/EP0957844B1/en not_active Expired - Lifetime
- 1996-05-21 DE DE69631069T patent/DE69631069T2/en not_active Expired - Lifetime
- 1996-05-21 DK DK96916559T patent/DK0957844T3/en active
-
1999
- 1999-05-28 US US09/322,636 patent/US6145505A/en not_active Expired - Lifetime
-
2000
- 2000-06-12 US US09/591,874 patent/US6871650B1/en not_active Expired - Fee Related
-
2002
- 2002-03-28 US US10/113,109 patent/US6679266B2/en not_active Expired - Lifetime
-
2004
- 2004-02-12 US US10/779,541 patent/US20040159324A1/en not_active Abandoned
- 2004-02-23 US US10/785,855 patent/US20040163651A1/en not_active Abandoned
- 2004-05-14 US US10/845,645 patent/US7428904B2/en not_active Expired - Fee Related
- 2004-05-14 US US10/846,047 patent/US20040211429A1/en not_active Abandoned
-
2006
- 2006-07-05 JP JP2006185643A patent/JP4317555B2/en not_active Expired - Lifetime
- 2006-07-31 US US11/497,468 patent/US8066007B2/en not_active Expired - Fee Related
-
2007
- 2007-02-26 US US11/711,444 patent/US20070144528A1/en not_active Abandoned
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102949261A (en) * | 2012-10-25 | 2013-03-06 | 中国人民解放军第三军医大学第一附属医院 | Special-shaped anti-dropping seminiferous duct sterilization apparatus |
CN102949261B (en) * | 2012-10-25 | 2014-09-10 | 中国人民解放军第三军医大学第一附属医院 | Special-shaped anti-dropping seminiferous duct sterilization apparatus |
Also Published As
Publication number | Publication date |
---|---|
US20040211429A1 (en) | 2004-10-28 |
JP2006314809A (en) | 2006-11-24 |
JP4317555B2 (en) | 2009-08-19 |
US20070144528A1 (en) | 2007-06-28 |
AU5926796A (en) | 1996-12-30 |
US8066007B2 (en) | 2011-11-29 |
EP0957844A1 (en) | 1999-11-24 |
US20040163651A1 (en) | 2004-08-26 |
DE69631069D1 (en) | 2004-01-22 |
US6145505A (en) | 2000-11-14 |
EP0957844B1 (en) | 2003-12-10 |
AU707047B2 (en) | 1999-07-01 |
US7428904B2 (en) | 2008-09-30 |
CA2221332A1 (en) | 1996-12-19 |
WO1996040023A1 (en) | 1996-12-19 |
ATE255866T1 (en) | 2003-12-15 |
US6871650B1 (en) | 2005-03-29 |
US20070044808A1 (en) | 2007-03-01 |
ES2210370T3 (en) | 2004-07-01 |
DK0957844T3 (en) | 2004-03-29 |
PT957844E (en) | 2004-03-31 |
JPH11506631A (en) | 1999-06-15 |
US20040206358A1 (en) | 2004-10-21 |
DE69631069T2 (en) | 2004-10-07 |
US6176240B1 (en) | 2001-01-23 |
EP0957844A4 (en) | 2000-02-02 |
US20020100480A1 (en) | 2002-08-01 |
US6679266B2 (en) | 2004-01-20 |
US20040159324A1 (en) | 2004-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2221332C (en) | Contraceptive transcervical fallopian tube occlusion devices and their delivery | |
US7686020B2 (en) | Contraceptive transcervical fallopian tube occlusion devices and methods | |
EP0957845B1 (en) | Contraceptive transcervical fallopian tube occlusion devices having mechanical fallopian tube attachment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |
Effective date: 20160524 |